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ABSTRACT OF THESIS 
 
 
ELUCIDATING THE ROLE OF LIGHT-INDUCED CIRCADIAN DISRUPTION ON 
ATHEROSCLEROSIS IN APOLIPOPROTEINE-DEFICIENT MICE 
 
Circadian rhythms are approximately 24-hour oscillations of nearly every biological 
process in the body. The circadian system coordinates these rhythms of physiology and 
behavior with environmental cycles such as the light-dark cycle. Shift workers, who 
experience irregular exposure to the light-dark cycle, have chronically disrupted circadian 
rhythms and increased risk of developing cardiovascular disease, but the mechanisms are 
unknown. Our studies investigated the effects of light-induced circadian disruption on 
atherosclerosis in ApolipoproteinE-deficient (ApoE-/-) mice. We found that male ApoE-
/- mice housed in constant light for 12 weeks, which results in severe disruption of 
circadian rhythms or arrhythmicity, developed significantly more atherosclerosis 
compared to mice in control light-dark conditions, and this increase was attributed to 
increased atherogenic VLDL/LDL cholesterol fractions. Next, we mimicked circadian 
disruption experienced by shift workers by housing ApoE-/- mice in chronic jet lag 
conditions where the light-dark cycle was advanced by 6-hours every week for 12 weeks. 
In female ApoE-/- mice, we found that that chronic jet lag caused a 70% increase in 
atherosclerosis and a 23% increase in cholesterol, which was in VLDL/LDL fractions. 
Together, these data show that light-induced circadian disruption increases 
atherosclerosis, in part via exacerbated dyslipidemia. 
 
KEYWORDS: Atherosclerosis, circadian disruption, shift workers, ApolipoproteinE-
deficient mice, circadian rhythms, cardiovascular disease  
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CHAPTER 1.  INTRODUCTION 
1.1 What are circadian rhythms? 
Circadian rhythms are approximately 24-hour oscillations of gene expression, 
physiology, and behavior1. These daily rhythms are called “circadian,” a term that was 
coined in 1959 by Franz Halberg from the Latin words ‘circa diem’ which translates to 
“about a day2.” These rhythms are entrained, or synchronized, to the daily cycles of light 
and temperature caused by the rotation of the Earth on its axis. Organisms from bacteria 
to mammals have evolved an endogenous time keeping mechanism (or circadian clock) 
to help them anticipate environmental cues such as the light-dark cycle3. 
There are numerous examples of circadian rhythms in mammals. Locomotor 
activity is one of the most commonly observed circadian rhythms4-8. Locomotor activity 
rhythms are nocturnal, diurnal, or crepuscular in night-active, day-active, or dawn/dusk-
active animals, respectively8. A lesser known circadian rhythm is the daily cycle of 
eating. Typically food intake rhythms peak at the same phase as locomotor activity, so 
that animals are consuming calories when they are necessary to fuel activity9. 
Additionally, several hormones have been shown to exhibit rhythmic oscillations. Two of 
the most well-characterized hormones are cortisol and melatonin. When entrained to the 
light-dark cycle, cortisol gradually increases before awakening and peaks during the day, 
while melatonin levels begin to increase approximately 2-hours before bedtime, peak 
during sleep, and decrease shortly after waking10-13.  
There are also circadian rhythms in numerous physiological, genetic, biochemical, 
metabolic, and immune processes. It has long been known that blood pressure exhibits 
circadian rhythmicity in humans14. Blood pressure follows a circadian pattern with a 
decline during sleep followed by a rapid increase in the morning and upon waking14,15. 
Microarray studies have shown that many genes in tissues such as the liver, heart, and 
fibroblasts are regulated by the circadian system16-21. Additionally, biochemical 
processes, such as biosynthesis of cholesterol in mice, are controlled by the circadian 
system16,20,22,23. Moreover, metabolic processes involved in insulin release and liver and 
adipose tissue function are under circadian control24-26. Furthermore, there is a rhythm of 
the quantity of immune cells in circulation27,28. These numerous biological processes 
demonstrate the crucial role of the circadian timing system.  
 
1.1.1 Historical observations of circadian rhythms 
Observations of rhythms date back thousands of years. These observations were 
first tested experimentally in the 18th century. In 1729, the French scientist Jean Jacques 
d’Ortous de Mairan documented the daily leaf movements, which he called sleep 
movements, of the plant Mimosa pudica29. de Mairan’s observations led him to ask if the 
daily leaf movements were generated by the daily changes of light and dark. He answered 
this question by placing a Mimosa pudica in a dark cupboard and monitored the changes 
in leaf shape across the day. He observed that the rhythms of leaf movements persisted in 
the absence of light. de Mairan concluded that “the sensitive plant thus senses the sun 
without seeing it in any way29.” Although his assertion was incorrect, his experiment was 
the first to demonstrate the existence of endogenously generated leaf movements in 
Mimosa pudica. 
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de Mairan’s study would be further validated by Duhamel de Monceau in 1758 by 
excluding temperature variation as a factor driving leaf movements30. de Monceau 
observed similar leaf movements in plants housed in a dark wine cave adding further 
validity to the idea of an endogenous clock30. Despite similar observations as de Mairan, 
de Monceau thought that the plants closed their leaves in the cave, during the night, due 
to the nightly temperature drop. Thus, he followed up his own cave experiment by 
placing plants in a hothouse that had a constant and high temperature30. From these two 
experiments, de Monceau concluded that neither light nor temperature was driving the 
changes in daily leaf orientation and that some other variable in the environment was 
causing this phenomenon30. Despite not knowing it at the time, de Monceau’s study was 
the first to demonstrate that circadian rhythms were temperature compensated. 
For the next 100 years, the study of biological rhythms was almost exclusively 
driven by studies of “sleep movements” of plants. Even Charles Darwin published an 
entire manuscript on the Movement of Plants and argued that daily rhythms were 
endogenously generated in plants31. However, this idea was challenged by several 
prominent plant scientists. Plant physiologist Wilhelm Pfeffer suspected that light leaking 
into De Mairan and de Monceau’s darkrooms invalidated their data and he continued to 
suggest the presence of some external, geophysical Factor X32. After extensive attempts 
to find Factor X, he would ultimately concede that the sleep movements of plant leaves 
were endogenously generated33.  
Two botanists, Auguste de Candolle and Erwin Bünning, argued against the idea 
of Factor X. In 1832, de Candolle observed the daily rhythms of Mimosa pudica leaf 
movements housed in constant light had a period shorter than 24-hours when compared 
to natural light-dark conditions34. He concluded that since the period of the behavioral 
rhythm of the plants gradually dissociated environmental light-dark cycle, no cue 
associated with the light-dark cycle was responsible for the rhythm34. Erwin Bünning 
came to similar conclusions by housing bean plants in constant light35. He similarly 
demonstrated that the period of plant leaf’s rhythmic movements deviated from 24-hours 
when housed in constant light35. These studies, along with others, provided the evidence 
needed to conclude the existence of endogenously generated rhythms in plant leaf 
movements.  
These experiments demonstrating an endogenous clock in plants were soon 
followed by studies in animal models. The first animal study showing an endogenously 
generated rhythm was that of pigment change in Hippolyte varians36. After observing the 
crustacean’s color change depending on the “quality of the light” and that enucleation 
would eliminate this color change until the eyes regenerated, it was suggested that the 
variation in light levels acted through the eyes and nervous system to alter color36. 
Another extensive study into the activity rhythms of rats, housed in constant darkness, 
showed that spontaneous locomotor activity remained rhythmic37. This persistence of 
rhythmicity also had a period that deviated slightly from 24-hours37, which is now 
considered indisputable evidence of endogenous generation.  
During her early studies into the biological clock in the honeybee, Ingeborg 
Beling trained individually marked bees to fly to a dish of sugar water during certain 
times of the day38. After accounting for several environmental cues, she observed that the 
bees would return at the trained times even when the sugar water was removed38. She 
trained the bees to show up at any time or multiple times throughout the day, but they 
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could only be successfully trained when the interval between visits was ~24-hours38. She 
would describe this phenomenon as time memory, although she could not conclusively 
determine if the bees had an internal clock controlling behavior.  
Another fundamental study assessed the sun-compass behavior of starlings39. 
Starlings were trained to fly in a particular compass direction towards a food source. It 
was thought that the birds were using the sun’s azimuth as a compass to know where to 
fly. To test this idea, the birds were placed in a laboratory with a fixed artificial light 
acting as the sun39. Every hour, when the birds flew to where the food should be, they 
appeared to add 15° to the angle relative to the artificial light39. One idea for this 
observation was that the birds had access to some highly accurate clock that would allow 
them to compensate for the sun’s movement across the sky39. Rock Pigeons that were 
entrained to a 6-hour phase advance showed a 90° change in flight direction when 
released into the wild40. The importance of using an internal clock to correctly predict 
where the sun will be in the sky was demonstrated by shifting the clock. 
Despite overwhelming evidence, some researchers still did not accept the 
presence of an endogenous clock. One prominent voice was endocrinologist Frank 
Brown, who continued to attribute behavioral timing to some Factor X (although he 
would later admit that there might be an endogenous clock)41. The ultimate test that re-
examined the endogenous vs exogenous (Factor X) idea of the clock came in 1984 when 
Neurospora crassa (bread mold) was sent into space42. On Earth, the fungus would 
unidirectionally grow in test tubes in a rhythmic manner. If Factor X was the exogenous 
Earth time cue, then Neurospora would not grow rhythmically in space (which is devoid 
of Factor X). Sulzman observed that the free-running period in space was similar to that 
on Earth42. This study provided evidence that there was no Factor X and solidified the 
presence of an endogenously generated biological clock as was originally demonstrated 
by De Mairan29. 
 
1.1.2 The fundamental properties of circadian rhythms 
The modern field of circadian biology was pioneered by Colin Pittendrigh and 
Jürgen Aschoff43. In 1960, at the Cold Spring Harbor Symposium on Biological Clocks, 
Pittendrigh and Aschoff presented their views that circadian rhythms were ubiquitous and 
follow fundamental properties (or rules). By working with numerous model organisms, 
Pittendrigh and Aschoff helped establish the fundamental properties of circadian 
rhythms. In order to be called circadian, a biological rhythm must meet the following 
criteria. First, the rhythm must be endogenously generated and have a free-running period 
(tau) of approximately 24-hours that persists in the absence of external cues (zeitgebers). 
This property would be further developed with the addition of Aschoff’s rule44. This rule 
states that, for nocturnal organisms, tau in constant light is longer than in constant 
darkness and, for diurnal animals, tau in constant light is shorter than in constant 
darkness. Second, the rhythm must entrain to external environmental cycles such as the 
light-dark cycle. Third, the rhythm must exhibit temperature compensation. Without strict 
adherence to these fundamental principles, circadian rhythms cannot be distinguished 
from those that are a response to environmental 24-hour cycles.  
The first fundamental principle of circadian rhythms is the endogenous 
persistence of rhythmicity in the absence of rhythmic external zeitgebers. Circadian 
rhythms that persist in constant conditions with a period (tau, the time taken for each 
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cycle to repeat) slightly different from 24-hours are called free-running6. This means that 
an external environmental cycle is not imposing a rhythm on the organism, rather the 
rhythm is an endogenously generated, self-sustained oscillation. Although these free-
running rhythms are endogenously generated, there is slight variability in period length 
(either longer or shorter than 24-hours). Thus, free-running rhythms are strong evidence 
of an endogenous biological timekeeping mechanism because the rhythm persists despite 
the organisms not being exposed to any environmental zeitgebers.  
Free-running rhythms in mammals were first reported in the early 1900s when 
Curt Richter measured wheel-running behavior in rats45,46. He found that wheel-running 
behavior was periodic (mostly nocturnal) in light-dark conditions and continued in 
constant conditions7. In human studies, body temperature was the factor most widely 
used to assess endogenous rhythms. Sleep researcher Nathaniel Kleitman and his 
assistant Bruce Richardson confined themselves in Mammoth Cave, Kentucky for 32 
days47. The cave environment was constant with respect to temperature and light, thus 
allowing them to try and entrain to a 28-hour period47. Daily body temperature 
measurements showed that each man had a slightly different period, suggesting the 
presence of an endogenous clock in humans47. Further evidence for endogenous rhythms 
was from the human isolation studies where individuals were housed in former World 
War 2 underground bunkers, which were devoid of timing cues, for several weeks6. 
Human subjects were permitted to eat, sleep, and perform tasks as they wished6. 
Continuous core body temperature, urine output, and activity monitoring showed the 
persistence of a self-sustained circadian oscillator with an average free-running period of 
25-hours6.  
The second fundamental principle of circadian rhythms is the ability to be 
entrained by an environmental cue (or zeitgeber) with an approximately 24-hour period. 
The German term zeitgeber, meaning ‘time giver,’ was coined by Jurgen Ashoff48. Under 
natural conditions, circadian oscillations are entrained to repeated environmental inputs 
such as the light-dark cycle44. Entrainment is the process by which an organism aligns its 
endogenous period with that of a rhythmic exogenous cycle. Once entrainment occurs, a 
stable phase relationship exists between the endogenous pacemaker and the 
environmental zeitgeber,49 resulting in both rhythms having equal periods50. This allows 
the internal clock of an organism to estimate external time. 
The third fundamental principle of circadian rhythms is temperature 
compensation. Temperature compensation was first inferred by Pittendrigh as an essential 
property of circadian rhythms51. Temperature compensation allows the endogenous clock 
to accurately maintain time under varying environmental temperatures that are within the 
physiological tolerance range of the organism. The Q10 coefficient explains the changes 
in the rates of metabolic processes by a 10°C change in temperature. As described by 
Van’t Hoff’s rule, the rate of a biochemical reaction with a Q10 of 2 or higher will 
increase by a factor of 2 or more with a 10°C temperature increase52,53. A Q10 equal to 1 
indicates no change in the rate of a reaction to a 10°C temperature increase, which has 
been shown in several tissues and organisms51,54-60. Thus, the idea of temperature 
compensation explains why the speed of the clock (period) remains constant in response 
to a wide range of environmental temperatures.  
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1.1.3 Photic entrainment of circadian rhythms 
One of the three fundamental properties of circadian rhythms is the ability to be 
entrained by an environmental zeitgeber. However, Colin Pittendrigh and Jürgen Aschoff 
had differing views about the mechanism of entrainment61. Pittendrigh focused on the 
nonparametric (discrete) model (entrainment achieved by discrete resetting events), while 
Aschoff proposed the parametric (continuous) model (entrainment achieved by 
modulating the rate of cycling)44,49,62. These models of entrainment utilized light as the 
entraining agent to align the endogenous period to that of the environmental light-dark 
cycle. The nonparametric model of entrainment proposes that an organism’s response to 
light is modulated based on the phase at which the light is presented. According to this 
model, circadian rhythms are instantaneously entrained by discrete transitions in the 
light-dark cycle (on and off). This response can be seen by giving a single light pulse to 
an organism under constant conditions. The presence or absence of light at discrete times 
of the day (dawn and dusk) cause an instantaneous phase shift that aligns the endogenous 
period of the organism to that of the environmental light-dark cycle44,61. Thus, exposure 
to light during the early part of an organism’s dark phase results in a phase delay, 
whereas light during the late part of the dark phase will result in a phase advance, while 
exposure to light during the light phase will not elicit a response44. These different 
responses can be seen by constructing a phase response curve (PRC) for the organism. 
The PRC is used to predict how an individual organism responds and entrains to 
the light-dark cycle. First described by Patricia DeCoursey63, PRCs have been 
constructed in numerous models64. A PRC is a plot of phase shifts of the endogenous 
rhythm and is comprised of three distinct zones: light exposure in the dead zone 
(subjective day) has no effect on phase, while light exposure during the subjective night 
causes phase shifts. Light exposure during the early night elicit a phase delay, while light 
exposure during the late night elicits a phase advance. The shape of the PRC is similar 
whether the behavioral rhythm (diurnal vs nocturnal) peaks during the day or at night65.  
This model of entrainment seems to be an ideal model since transitions in the light-
dark cycle mostly resemble the natural dawn and dusk transitions. However, the 
nonparametric model cannot account for entrainment in organisms that do not experience 
dawn and dusk transitions66. Aschoff proposed the parametric model after observations of 
how light affected the period in diurnal and nocturnal organisms62. Aschoff’s parametric 
model of entrainment suggests that light intensity will either accelerate or decelerate the 
clock at specific phases of the day allowing for the endogenous free-running period to 
equal that of the light-dark cycle62. Unlike the nonparametric model which suggests that 
free-running period is constant and changes in period are only due to phase shifts, the 
parametric model suggests the free-running period can either speed up or slow down in 
response to light across the day49. Pittendrigh would later describe Aschoff’s 
generalizations about free-running periods in different organisms under different 
conditions as Aschoff’s Rules44. However, these rules cannot be fully explained by a 
PRC which is used for phase predictions in the nonparametric model.  
The parametric model assumes the free-running period is either accelerated or 
decelerated depending on the intensity of light at specific phases of the circadian cycle62. 
This change in velocity of the pacemaker is represented by a velocity response curve 
(VRC), which can be estimated from the PRC67. Thus, the parametric effects of light can 
be described by the nonparametric effects of light seen in PRCs. The VRC illustrates the 
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change in velocity of the oscillator under conditions of constant light68. Constant light 
allows light to stimulate all points of the PRC resulting in a phase shift similar to the 
same organism in constant darkness. An organism with a large A:D ratio in constant light 
would have a decreased free-running period compared to an organism with a small A:D 
ratio which would have a longer free-running period. 
 
1.2 Circadian clocks 
The circadian system in mammals is composed of a central pacemaker and multiple 
peripheral oscillators69. In mammals, the “master” circadian pacemaker is the 
hypothalamic suprachiasmatic nucleus (SCN). The SCN receives information from the 
intrinsically photosensitive retinal ganglion cells (ipRGCs) of the eye via the 
retinohypothalamic tract and entrains to the environmental light-dark cycle70-75. The SCN 
then coordinates the phases of peripheral circadian clocks located throughout the body70. 
These peripheral clocks then regulate local physiology1. 
 
1.2.1 Discovery of the mammalian pacemaker 
The discovery of the master pacemaker in rodents was initiated in 1967 by Curt 
Richter who observed that ablation of the ventromedial hypothalamus in rats eliminated 
behavioral rhythms76. Almost 10 years later, the SCN was identified as the master 
pacemaker by the labs of Irving Zucker and Robert Moore. Zucker and Moore had 
similar interests in visual pathways. Irving Zucker’s graduate student, Friedrich Stephan, 
was aware of the research being done by reproductive physiologists studying the estrous 
cycle in hamsters77. Stephan was interested in how the visual pathways to the 
hypothalamus influenced neuroendocrine functions such as the luteinizing hormone 
surge. Robert Moore was also investigating the pathways that relayed light information 
from the eyes to the brain. Moore discovered a pathway from the retina that terminated at 
the SCN78. Moore used tract tracing from the retina of the eye to identify the pathway 
that terminated at the SCN was the retinohypothalamic tract79,80. 
Moore’s discovery of the retinohypothalamic tract motivated both Stephan and 
Moore to focus their research on the SCN as the terminal site of light input to the 
circadian system. Both groups previously described the SCN as a light relay to some 
other central pacemaker, however, upon lesioning the SCN, both groups observed 
arrhythmicity78,81. Stephan discovered that a complete lesion of the SCN eliminated the 
circadian rhythms of drinking behavior in rats81. Moore found that SCN lesion eliminated 
the adrenal corticosterone rhythm in rats78.  
Following the lesion studies, several groups employed in vivo and in vitro 
techniques to assess anatomical structure and physiological function(s) of the SCN. Initial 
autoradiographic metabolic imaging and electrophysiological studies demonstrated that 
the SCN neurons oscillate in vivo. The first autoradiographic metabolic imaging study of 
the SCN used the carbon14 labeled 2-deoxyglucose uptake method to demonstrate that 
metabolic activity in the SCN is high during the day82. Another group showed that the 
multiple unit electrical activity firing rate in the in vivo SCN of rats was rhythmic and 
peaked during the day83. The pivotal part of this study came when the SCN was 
surgically isolated from the surrounding structures. The isolated SCN remained rhythmic, 
while the surrounding structures lost rhythmicity, suggesting the rhythm of the SCN is 
not dependent on any other brain structure83. These slice electrophysiology studies 
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demonstrated that the neuronal electrical activity in the SCN has sustained oscillation in 
vitro. 
The in vivo studies demonstrated the rhythmicity of the SCN; however, it wouldn’t 
be until the in vitro isolation of the SCN before the autonomy of the SCN could be 
confirmed. Three independent experiments demonstrated that the rat SCN was rhythmic 
in vitro. Green and Gillette took SCN slices and maintained them in vitro for 24-hours84. 
They sampled individual neurons throughout the SCN and observed firing rate 
rhythmicity84. The firing rates and were entrained light-dark cycle before sampling and 
peaked during the subjective day85. Another group conducted similar in vitro 
experiments, but also collected retrochiasmatic and arcuate neurons in addition to SCN86. 
Tissue slices were maintained in vitro for 30-hours86. Rhythmic firing rates were 
observed in the SCN but not in the retrochiasmatic or arcuate neurons86. The in vitro 
results from Shibata provided additional evidence on how prior environmental light-dark 
cycles influenced the SCN87. Rats were maintained in either normal or reversed light-
dark cycles for at least one month87. After in vitro measurements of SCN electrical 
activity, it was observed that the firing rates shifted to the light phase of the entrained 
light-dark cycles prior to collection87. 
A drawback of these three studies was the inability to maintain the SCN in vitro for 
multiple cycles. A solution to this problem was to sample the SCN beyond the first cycle 
(i.e. beyond 24-hours in culture)88. The electrical activity of the in vitro SCN remained 
rhythmic for up to 60-hours. The ability to record electrical activity beyond one cycle 
allowed researchers to determine if the SCN could be reset in vitro. Timed administration 
of cAMP analogs caused phase advances of the rhythm that persisted for several cycles88. 
This demonstrated that the SCN could be entrained in an in vitro environment. These in 
vivo and in vitro studies unequivocally demonstrated that the SCN was a tissue-based 
clock, independent of any other brain structures.  
The physiological function of the SCN was tested by in vivo transplantation 
techniques. It was shown that ablation of SCN tissue in neonate rats discouraged retinal 
projections to the SCN and rendered locomotor and drinking activity arrhythmic in 
adulthood89. However, transplantation of fetal SCN tissue into adult hamsters restored 
locomotor activity rhythms and, in some individuals, retinal input and SCN efferents 
were established90. This study further demonstrated that the SCN functioned as a master 
pacemaker. However, it was unclear if the donor SCN was responsible for the period seen 
in the host. This was investigated with the observations made in the Tau mutant 
hamster91. The spontaneous Tau mutation imparted a shortened period of 22-hours in 
heterozygotes and 20-hours in homozygotes91. By using SCN tissue from Tau mutant 
donors, it was shown that the host rhythm was restored and with the period of the 
donor92. 
 
1.2.2 Molecular timekeeping of circadian clocks 
The initial discoveries of the circadian clock genes were in Drosophila and later in 
mammals. The first clock gene described was characterized in Drosophila that had 
abnormal eclosion periods93. After administration of the mutagen ethyl methane sulfonate 
to Drosophila, eclosion and locomotor activity of the offspring was monitored93. Out of 
the nearly 2000 offspring, only three mutants displayed altered or disrupted circadian 
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rhythms. One had a 28-hour period, one had a 19-hour period, and the third mutant was 
arrhythmic93. However, it wasn’t until over a decade later that gene would be cloned.  
In 1984, the first circadian clock gene period (per) was successfully cloned and 
rescued in Drosophila94-97. Several years later, Jeffery Hall and Michael Rosbash made 
several discoveries that led them to propose a per feedback loop. They observed that per 
mRNA peaked several hours before the PERIOD (PER) protein, PER was being 
translocated from the cytoplasm back into the nucleus, and PER overexpression 
decreased per mRNA levels98-100. In 1994, the next Drosophila circadian gene timeless 
(tim) was discovered by Amita Seghal and Michael Young101,102. Tim was shown to 
oscillate in phase with per and the TIM protein interacted with PER to help PER re-enter 
the nucleus102. Not long after, the final piece of the feedback loop was discovered when 
PER and TIM were shown to inhibit Drosophila CLOCK activity103. These studies 
ultimately demonstrated that the circadian clock genes Clock and Bmal drive their own 
negative feedback.  
There are two molecular feedback loops that govern mammalian circadian rhythms. 
In the primary loop of the rodent SCN, positive elements BMAL1 and CLOCK 
heterodimerize and bind to regulatory DNA sequences (E-boxes) in the promoter regions 
of Period and Cryptochorme104,105. Acting as transcription factors, BMAL1:CLOCK 
upregulate Period and Cryptochrome genes during the circadian day104,106. The proteins 
PERIOD and CRYPTOCHROME leave the nucleus and enter the cytoplasm where they 
heterodimerize107. The negative elements, PER:CRY heterodimers, are phosphorylated 
and then translocate back into the nucleus and inhibit the transcription factor activity of 
BMAL1:CLOCK heterodimer during the circadian night104,106. Over time, the PER:CRY 
proteins are degraded and their autoregulatory feedback is reduced, allowing 
CLOCK:BMAL1 to reinitiate transcription.  
In the secondary loop, positive elements BMAL1 and CLOCK heterodimerize and 
bind to E-boxes in the promoter regions of Ror and Rev-erb in phase with 
transcriptional regulation of Period and Cryptochrome106,108-111. Ror and Rev-erb mRNAs 
enter the cytoplasm, where they are translated into ROR and REV-ERB and then 
translocate back into the nucleus104. Once in the nucleus, they feed back on Bmal1 to 
either inhibit (RORs) or activate (REV-ERBs) transcription of Bmal1 through binding of 
retinoic acid-related orphans receptor response elements (ROREs)104. 
 
1.3  What is atherosclerosis? 
Cardiovascular disease (CVD) is an all-encompassing term that describes diseases 
of the blood vessels and heart and is the leading cause of death of men and women in 
America112. Impaired vascular endothelial function and inflammation results in the 
formation of an atherosclerotic lesion. The word atherosclerosis is derived from the 
Greek words artēria ‘gruel’ and sklerosis ‘hardening.’ Atherosclerosis is the primary 
cause of CVD, which can result in myocardial infarction or stroke. Briefly, 
atherosclerosis is initiated by lipid infiltration into atrial vessel walls and oxidation and 
modification of those lipids, which ultimately lead to a chronic inflammatory state113.  
Over time, the disease progresses as the lipid-filled plaque increases in size and drives 
greater inflammatory responses. Advanced-state lesions can grow large enough to 
occlude blood flow, however, the most common clinical outcome of atherosclerosis is the 
formation of a thrombosis114, which can lead to myocardial infarction or stroke. 
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1.3.1 Basic mechanisms of atherosclerosis 
 
1.3.1.1 Lipoprotein transport 
Lipids are hydrophobic compounds that are soluble in organic solvents and 
relatively insoluble in water115. Of the lipids found in blood, serum cholesterol and 
triglycerides play the most important role in the pathogenesis of atherosclerosis116,117. 
Lipids are transported in circulation within lipoproteins. Lipoproteins are composed of a 
hydrophobic core of cholesterol esters and triglycerides and a shell of free cholesterol and 
apolipoproteins118. Lipoproteins are synthesized in small intestinal enterocytes 
(chylomicrons) and hepatocytes (VLDL and HDL). The chylomicrons, VLDL, and HDL 
transport intestinal triglycerides, hepatic cholesterol, or cholesterol esters to extrahepatic 
(chylomicrons and VLDL) or hepatic (HDL) tissues respectively. To release their lipid 
contents onto extrahepatic cells, chylomicrons and VLDL interact with the enzyme 
lipoprotein lipase119. As they release their lipid contents, they are remolded into smaller 
chylomicron remnants and LDL respectively120. Lipoprotein remnants are then returned 
and cleared from plasma by hepatocytes119. However, not all LDL is cleared and can 
accumulate within the endothelium of vessel walls. 
 
1.3.1.2 Lipoprotein retention and modification 
The endothelial layer has many atheroprotective functions such as preventing 
immune cell adhesion and inhibiting both extracellular matrix deposition and smooth 
muscle cell proliferation121. However, within the endothelial layer, the vascular 
proteoglycans biglycan and decorin are susceptible to lipid accumulation due to their 
interaction with the LDL surface protein ApolipoproteinB (ApoB)122,123. In a normal, 
healthy vascular wall cell, the rate of LDL influx greatly exceeds the rate of LDL 
retention124. This is because vascular wall cells have a high rate of LDL efflux due to the 
role of HDL in the reverse cholesterol transport system125. Thus, in a proatherogenic 
state, LDL retention is not due to increased influx, rather a dramatic decrease in 
lipoprotein efflux. Retention of LDL and successive LDL oxidation (ox-LDL) are key in 
the early stages of atherosclerosis development126. 
 
1.3.1.3 Monocyte adherence and differentiation 
In the response to injury hypothesis, the initial step in atherogenesis is endothelial 
denudation, which is a loss of endothelial cells along the intimal layer127. The endothelial 
layer has many atheroprotective functions such as preventing immune cell adhesion and 
inhibiting extracellular matrix deposition and smooth muscle cell proliferation121. Thus, 
injury to endothelial cells allows for these endothelial cell regulated processes to become 
disrupted128. Additionally, ox-LDL promotes an atherogenic environment by shifting the 
extracellular recognition from native LDL-Rs to scavenger receptors129. This induces 
inflammatory responses that are characterized by leucocyte (monocyte) recruitment to the 
site of the ox-LDL130. Once recruited, monocytes will differentiate into macrophages, 
target, and engulf ox-LDL. Uptake of ox-LDL by macrophages (via scavenger receptors) 
results in massive cholesterol accumulation. This massive cholesterol accumulation leads 
to the conversion of macrophages into foam cells130. 
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1.3.1.4 Plaque progression and thrombosis 
The process of ox-LDL uptake by macrophages activates the release of numerous 
cytokines and growth factors126. This, in turn, causes further recruitment of additional 
macrophages to the developing plaque. As more macrophages infiltrate the lipid-rich 
plaque, they cause the release of matrix metalloproteinase (MMP) and promote 
macrophage apoptosis that develops into a necrotic core131. In addition, vascular smooth 
muscle cells (VSMC) proliferate and infiltrate the developing plaque. As the VSMC 
proliferate, they produce extracellular matrix which aids in stabilizing the atherosclerotic 
plaque132. This leads to the formation of a fibrous cap and further stabilizes the plaque133. 
This fibrous cap serves as a barrier between the necrotic core, which is thrombogenic in 
nature, and inflammatory cells found in the blood133.  
As the plaque grows and ages, VSMC lose their ability to maintain stability of the 
plaque134. This allows inflammatory cells and MMP to slowly degrade the fibrous cap126. 
MMP are catabolic and promote degradation of the basement membrane and extracellular 
matrix increasing the probability of plaque rupture126. These processes promote plaque 
destabilization and rupture which leads to thrombosis. 
 
1.3.2 Risk factors for atherosclerosis 
Atherosclerosis is a multimodal disease that can be exacerbated by several risk 
factors including dyslipidemia, obesity, age, sex, cigarette smoking, diabetes, 
hypertension and inflammation113,135-140. Although independently identified as risk 
factors, several of these risk factors work in tandem to promote the development of 
atherosclerosis.  
Dyslipidemia is the elevation of triglycerides, cholesterol, or both. Currently, 
dyslipidemia is recognized as a leading risk factor for the development of 
atherosclerosis141. Epidemiological studies such as the Framingham, MRFIT, and The 
Seven Countries Studies have demonstrated that elevated blood cholesterol levels are 
associated with an increased risk of having a cardiovascular event142-144. Additionally, 
these and other studies have pointed towards low density lipoprotein cholesterol (LDL-C) 
being directly associated with cardiovascular events145. However, high density 
lipoprotein cholesterol (HDL-C) was shown to be inversely associated with 
cardiovascular events146. Therefore, it has been hypothesized that lowering LDL-C could 
reduce cardiovascular events also called the cholesterol hypothesis. 
Evidence supporting the cholesterol hypothesis comes from numerous studies 
involving statin therapy. Statins (HMG-CoA reductase inhibitors) are a drug class that 
inhibit the synthesis of cholesterol in the liver by the enzyme HMG-CoA reductase and 
increases LDL-C clearance by upregulating LDL receptors in hepatocytes147. Lipid 
lowering therapy using statins reduces the progression of atherosclerosis and improves 
clinical outcomes148,149. Additionally, numerous large-scale randomized controlled 
studies have demonstrated the beneficial effects of statins on patients with established 
coronary artery disease or who are at high risk of developing heart disease due to 
elevated LDL-C148,150-153. Moreover, meta-analyses across varying levels of 
atherosclerosis progression showed that statin therapy is associated with a reduction in 
coronary events and coronary-related death154. 
Although high LDL-C is widely accepted as an important causative factor of 
atherosclerosis, triglycerides also play a role in its development. The ApoB system 
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transports intestinal triglycerides to muscle for energy use or to adipose tissue for storage. 
As ApoB lipoproteins release triglycerides to tissues, they are remodeled into smaller 
triglyceride-rich chylomicron remnants. Most of these ApoB lipoproteins are then 
transported to the liver for recycling, but some become trapped in the artery wall and 
initiate the development of atherosclerosis. Thus, proper regulation of these lipoproteins 
is crucial for lipid homeostasis. 
The response to retention hypothesis is based on the premise that ApoB 
lipoprotein retention is the driving force behind the development of atherosclerosis122,155. 
In this model, hyperlipidemia induces lesion formation in susceptible arterial sites 
through the retention of ApoB-rich lipoproteins via their interaction with vascular 
proteoglycans122,156-159. Evidence to support lipid retention comes from several studies 
that have shown lipoprotein retention in the arterial wall is observed very shortly after 
inducing hyperlipidemia160,161. 
Obesity has become an epidemic in the modern world and is developing early in 
life162. Obesity is defined as having excess body fat and is a chronic metabolic disorder 
that has been linked to the development or progression of numerous comorbidities163-167. 
Considering many of these comorbidities, such as dyslipidemia and hypertension, are 
independent risk factors for atherosclerosis, obesity prevention is key to reducing 
atherosclerosis. The association between obesity and these other risk factors also makes 
studying obesity as a risk factor difficult. However, several groups have demonstrated an 
independent association between obesity and CVD risk168,169. 
Increasing evidence indicates that aging is also an independent risk factor for 
atherosclerosis and persists even when other risk factors are controlled. As vessels age, 
intimal and medial thickening occurs along with a gradual loss of arterial elasticity170. 
These aged vessels show similar pathological process that are seen in vessels with 
atherosclerosis171,172. 
There is relatively limited data suggesting sex as an independent biological risk 
factor for atherosclerosis173. Although there are limited data suggesting that sex is an 
independent risk factor for atherosclerosis, the sex differences observed may be due to 
the biological responses of lifestyle choices in men and women. When compared with 
men, women have a higher risk for myocardial infarction when exposed to risk factors 
such as cigarette smoking, dyslipidemia, hypertension, and diabetes mellitus174,175. This 
increased risk of myocardial infarction was contributed to an increased prevalence of 
CHD in women exposed to these risk factors174,175. However, men are more likely than 
women to engage in behaviors that increase risk factors associated with the development 
of atherosclerosis including cigarette smoking, dyslipidemia, presence of hypertension, 
and diabetes mellitus176-179. Thus, the role of sex as an independent risk factor for 
atherosclerosis remains uncertain. 
Cigarette smoking is another risk factor for atherosclerosis because it stimulates 
monocyte adhesion to the endothelium. Endothelial activation is when the endothelium 
produces adhesion molecules and chemotactic factors that drive monocyte adhesion and 
permeate into the vascular wall180,181. This produces vascular inflammation, which is one 
of the initial events leading to the formation of atherosclerotic plaques. Additionally, 
stimulation of nicotine receptors on the endothelium and vascular smooth muscle cells 
causes proliferation which may contribute to the neovascularization and growth of 
atherosclerotic plaques182.  
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Type 2 diabetes is characterized by insulin resistance, hypertension, dyslipidemia, 
and obesity183. Thus, type 2 diabetic patients are prone to CVD at higher rates compared 
with non-diabetics. Previous work has shown that high blood sugar has multiple effects 
on the development of atherosclerosis including overproduction of free radicals184 and a 
reduction in the availability of nitric oxide (allowing blood vessels to relax)185. In 
addition, the physical stress of diabetes induced hypertension on the vascular walls 
results in vascular damage that can promote and exacerbate atherosclerosis139. 
Blood pressure follows a circadian pattern with a decline during sleep followed by 
a rapid increase in the morning and upon waking14,15. Since blood pressure is calculated 
using cardiac output, the circadian rhythm of heart rate closely follows that of blood 
pressure186. During sleep, the parasympathetic nervous system reduces heart rate, and 
thus decreases blood pressure187. Normotensive and treated and untreated hypertensive 
individuals experience decreases in blood pressure during sleep188. However, nondippers 
(those whose blood pressure remains elevated during sleep) have been shown to have 
increased intimal-medial vessel thickness and increased prevalence of atherosclerotic 
plaques when compared to dippers189,190. 
 
1.3.3 Mouse models of atherosclerosis 
Wild-type C57BL/6J mice transport much of their plasma cholesterol on HDL, 
which drastically reduces cholesterol levels due to a highly efficient reverse cholesterol 
transport system191. Therefore, they are not a suitable mouse model for the study of 
atherosclerosis. Two of the most widely used mouse models of atherosclerosis are the 
low-density lipoprotein receptor deficient (Ldlr-/-) and the ApolipoproteinE-deficient 
(ApoE-/-) models. The Ldlr-/- model lacks a functional LDL receptor gene192. The LDL 
receptor is involved in clearance of apolipoproteinB100 (ApoB100)-containing VLDL 
and remnant lipoproteins from circulation192. However, these animals only develop small 
lesions on a chow diet and must be fed a high cholesterol and/or high-fat diet to produce 
a hyperlipidemic state to accelerate atherogenesis193-195.  
The ApoE-/- mouse model is a well-established preclinical model for studying the 
mechanisms of atherosclerosis196,197. ApolipoproteinE is synthesized mainly in the liver 
and brain and helps regulate the uptake of apolipoproteinB48 (ApoB48) containing 
chylomicrons, VLDL, and their remnants for clearance by hepatic LDL receptors197. 
Thus, ApoE-/- mice have poor lipoprotein clearance accompanied by accumulation of 
cholesterol-rich remnants in the blood197. These mice begin developing atherosclerosis 
around 12 weeks of age and when fed a high cholesterol and/or high-fat diet have 
accelerated atherosclerosis development197-199.  
 
1.4 Circadian disruption and cardiovascular disease (CVD) 
Circadian disruption is a term that encompasses many different forms of disruption. 
These can include misalignments between external rhythms, such as the light-dark cycle, 
and internal clocks or internal desynchronization between the SCN and peripheral clocks. 
Circadian disruption is pervasive in modern society. Shift work, defined as work 
schedules that occur outside the traditional 6am-6pm200,201, chronically disrupts circadian 
rhythms. According to the Bureau of Labor Statistics, 15-20 million Americans work full 
time on night or rotating shifts202,203. Shift workers are at a higher risk of developing 
metabolic and cardiovascular disease risk factors such as increased weight gain and 
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obesity 204-210, impaired cholesterol and triglyceride levels208,210-212, insulin resistance213, 
and type 2 diabetes214 when compared with dayshift workers.  Epidemiological studies 
have shown that shift work increases the risk of developing heart disease by 20-
40%215,216. In a study of nurses, those who were employed for ≥6 years of consecutive 
shift work had a 50% increased risk of developing heart disease216. Additionally, in a 
controlled laboratory study where young, healthy adults were exposed to a shift work-like 
protocol for 8 days, participants had increased blood pressure and adverse inflammation, 
which are associated with CVD217. Despite the demonstrated link between circadian 
disruption by shift work and CVD, the underlying mechanisms are largely unknown. 
 
1.4.1 Genetic disruption of the circadian system and CVD 
Several studies investigated the link between atherosclerosis and circadian 
disruption in mice by mutating the circadian clock genes Clock and Bmal1. ClockΔ19/ Δ19 
mutant mice on both the ApoE-/- or Ldlr-/- backgrounds developed more atherosclerosis on 
chow and atherogenic diet compared to controls218. Conventional (cKO) and adult-only 
(iKO) Bmal1-/- were generated on a Ldlr-/- background. Like the ClockΔ19/ Δ19 model, there 
were marked increases in atherosclerotic lesions in the cKO mice219. In contrast, in the 
iKO model, aortic inflammatory markers, body weight, and atherosclerosis were reduced 
compared to controls219. These data suggest a developmental role of Bmal1 in 
atherogenesis. 
Rev-erbα is an accessory component of the circadian molecular transcriptional-
translational feedback loop104. Knock down of Rev-erbα specifically in bone marrow on 
an Ldlr-/- background increased atherosclerotic lesion area, thus identifying Rev-erbα in 
macrophages as atherogenic220. Although there was no change in the total number of 
macrophages, there was an increase in the ratio of M1 (atherogenic) to M2 
(atheroprotective) lineages suggesting Rev-erbα is driving macrophages toward the M1 
phenotype220. This could result in increased inflammation and thus contribute to 
atherogenesis. 
Although these data suggest that disruption of circadian genes results in the 
development of atherosclerosis, the mechanisms by which this process occurs differs. 
Mice lacking global Bmal1 or with liver-specific deletion of Bmal1 on ApoE-/- and Ldlr-/- 
backgrounds had increased atherosclerotic lesions221. This increase was attributed to the 
development of hypertriglyceridemia and increased levels of plasma cholesterol esters in 
the global deletion, while liver-specific deletion showed decreased excretion of 
cholesterol into the bile221. ClockΔ19 mice lost circadian rhythms of circulating plasma 
triglycerides and developed mild hypertriglyceridemia222,223. It was also shown that 
ClockΔ19 mutants had macrophage dysfunction (improper uptake of oxidized LDL and 
cholesterol efflux) and a significant increase in lipid uptake by enterocytes218. However, 
unlike ClockΔ19, deletion of Bmal1 did not alter cholesterol metabolism, which suggests 
that there are different modes of action for the development of atherosclerosis in these 
models219. Additionally, deletion of Bmal1 in monocytes promoted the recruitment of 
Ly6chi monocytes, which attach to sites of endothelial inflammation then differentiate 
into macrophages, and increased atherosclerotic lesions224. These data demonstrate the 
roles played by circadian clock genes in atherosclerosis, thus providing proof of principle 
that circadian disruption in circadian genetic knockouts causes atherosclerosis. 
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1.4.2 Photic disruption of the circadian system and CVD 
Studies in healthy humans showed that short-term circadian disruption promoted 
the development of negative several cardiovascular disease risk factors. One cross-over 
design study exposed healthy individuals, 20-49 years of age, to two 8-day protocols217. 
One of the 8-day protocols included a 3-day inversion of the behavioral and light-dark 
cycle (i.e. similar to working the night shift for 3 nights). When compared to the control 
8-day protocol, the individuals developed hypertension and inflammatory markers. In 
another study, healthy individuals underwent a 10-day forced desynchrony protocol 
consisting of two control days followed by seven recurring 28-hour days225. The 
individuals in this study had increased CVD risk factors including acute hypertension and 
disrupted glucose metabolism225.  
Studies of mutant mice provide proof of principle that circadian gene disruption 
causes atherosclerosis. However, circadian gene mutations in humans are rare. Thus, 
perturbation of the circadian system by non-genetic means may be a better translational 
model for studying the effects of circadian disruption on CVD in humans. For example, 
one study suggested that a weekly inversion of the light-dark cycle increased 
atherosclerosis in ApoE-/- mice, although the data were not quantified226. 
Another study found that, after 15 weeks of alternating light-dark cycles, 
atherosclerosis was increased and the increase was attributed to a higher concentration of 
pro-atherogenic lesion macrophages227. Moreover, our lab recently showed that chronic 
exposure to constant light increased atherosclerosis in male ApoE-/- mice via an increase 
in VLDL/LDL cholesterol228. 
 
1.5 General project overview 
The circadian system is responsible for generating and entraining biological 
rhythms with 24-hour environmental cycles, such as the light/dark cycle. It is well-
established that shift workers, who experience chronic circadian disruption, are at 
increased risk of developing CVD. Circadian disruption is also pervasive due to work, 
school, and social obligations, and these modern lifestyles may also contribute to CVD. 
However, little is known about the mechanisms linking light-induced circadian disruption 
and CVD. To this end, we have designed two studies to elucidate the mechanisms that 
link light-induced circadian disruption and atherosclerosis. The goal of the first study was 
to establish a mouse model to study the effects of constant light-induced circadian 
disruption on atherosclerosis. The goal of the second study was to investigate the effects 
of chronic jet lag (CJL), a model of shift work, on atherosclerosis. These studies will help 
to gain a better understanding of the mechanisms of atherosclerosis that could be 
impacted by light-induced circadian disruption. 
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CHAPTER 2. PUBLICATION: CIRCADIAN DISRUPTION WITH CONSTANT LIGHT EXPOSURE 
EXACERBATES ATHEROSCLEROSIS IN APOLIPOPROTEINE-DEFICIENT MICE 
2.1 Main text 
Circadian disruption with constant light exposure exacerbates atherosclerosis in 
male ApolipoproteinE-deficient mice 
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Abstract 
 
Disruption of the circadian system caused by disordered exposure to light is pervasive in 
modern society and increases the risk of cardiovascular disease. The mechanisms by 
which this happens are largely unknown. ApolipoproteinE-deficient (ApoE-/-) mice are 
studied commonly to elucidate mechanisms of atherosclerosis. In this study, we 
determined the effects of light-induced circadian disruption on atherosclerosis in ApoE-/- 
mice. We first characterized circadian rhythms of behavior, light responsiveness, and 
molecular timekeeping in tissues from ApoE-/- mice that were indistinguishable from 
rhythms in ApoE+/+ mice. These data showed that ApoE-/- mice had no inherent circadian 
disruption and therefore were an appropriate model for our study. We next induced 
severe disruption of circadian rhythms by exposing ApoE-/- mice to constant light for 12 
weeks. Constant light exposure exacerbated atherosclerosis in male, but not female, 
ApoE-/- mice. Male ApoE-/- mice exposed to constant light had increased serum 
cholesterol concentrations due to increased VLDL/LDL fractions. Taken together, these 
data suggest that ApoE-/- mice are an appropriate model for studying light-induced 
circadian disruption and that exacerbated dyslipidemia may mediate atherosclerotic 
lesion formation caused by constant light exposure. 
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Introduction 
More than 600,000 people die every year in the U.S. from heart disease229. 
Atherosclerosis, the progressive accumulation of plaques in arteries, is the primary cause 
of cardiovascular disease (CVD), stroke, and myocardial infarction114. There are several 
well-established CVD risk factors including smoking, hypertension, elevated low-density 
lipoprotein (LDL) cholesterol, obesity, diabetes, and inflammation135,230,231. 
Epidemiological and clinical studies have shown that circadian disruption also increases 
the risk of CVD216,232,233.  
 Circadian rhythms are 24-hour oscillations in gene expression, physiology, and 
behavior. These rhythms are entrained, or synchronized, with environmental cycles. This 
allows organisms to anticipate predictable daily changes in the environment to increase 
their fitness234-236. Mammalian circadian rhythms are generated by molecular clocks that 
are located in nearly every tissue in the body70. These clocks are organized hierarchically. 
The retina detects and sends information about the light-dark cycle to the master clock in 
the suprachiasmatic nucleus (SCN). The SCN, in turn, coordinates the timing of clocks 
located throughout the body70. At the molecular level, the timekeeping mechanism is a 
negative transcription/translation feedback loop237. The transcription factors BMAL1 and 
CLOCK dimerize and drive the transcription of the Period and Cryptochrome genes. 
Then PERIOD and CRYPTOCHROME feed back and inhibit the transcription factor 
activity of BMAL1 and CLOCK, thereby suppressing their own transcription. This 
feedback loop takes approximately 24-hours to complete and therefore generates a 24-
hour molecular rhythm. 
 Recent meta-analyses show that shift workers, who experience chronic circadian 
disruption and disordered exposure to light and food intake, have 20-40% increased risk 
of CVD232,233. Laboratory studies have also demonstrated a causal link between 
disruption of circadian rhythms and CVD risk factors. In a controlled laboratory study 
where young, healthy adults were exposed to a shift work-like protocol for 8 days, 
participants had increased blood pressure and adverse inflammation, which are associated 
with CVD217. Despite the demonstrated link between circadian disruption and CVD, the 
underlying mechanisms are largely unknown. The goal of this study was to establish a 
mouse model for studying the mechanisms of light-induced circadian disruption on 
atherosclerosis. 
Previous studies in mice have shown that genetic disruption of the circadian 
molecular timekeeping mechanism causes cardiovascular pathology218,219,221,224,238. Mice 
lacking functional Bmal1, and Clock∆19 mutants, both of which have impaired or 
arrhythmic circadian clocks, had increased pathological vascular remodeling compared to 
mice with functional clocks238. Bmal1-/- or Clock∆19 mice, on ApolipoproteinE-deficient 
(ApoE-/-) or Low-density lipoprotein receptor deficient (Ldlr-/-) backgrounds, had 
dysfunctional cholesterol metabolism and transport and increased atherosclerosis218,221. In 
addition, deletion of Bmal1 in myeloid cells or Rev-erbα in bone marrow-derived cells 
increased atherosclerosis in mice, demonstrating a role of circadian clocks in the immune 
system in regulating atherosclerosis220,224. However, one study showed that inducible 
deletion of Bmal1 in adulthood did not increase atherosclerosis, suggesting that the 
detrimental effects of BMAL1 deficiency may be developmental219. 
Overall, studies of mutant mice have provided proof of principle that circadian 
gene mutations increase atherosclerosis. A few studies have also shown that genetic 
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variations of circadian genes are associated with CVD risk factors in humans and 
circadian gene expression is altered in the cells in the vascular wall by atherosclerosis239-
244. However, many more studies have shown that disruption of circadian rhythms via 
environmental disruptors, such as disordered exposure to light and food during shift 
work, exposure to artificial light at night, and late-night snacking, increases the risk for 
CVD in humans217,233,245-247. Thus, perturbation of the circadian system by non-genetic 
means in mice may be ideal for modeling the effects of circadian disruption on 
atherosclerosis in humans.  
The goal of this study was to establish a model system to study the effects of 
light-induced circadian disruption on atherosclerosis. The ideal mouse model should have 
normal circadian rhythms and normal responsiveness to light and those rhythms should 
be susceptible to disruption by perturbation of the light-dark cycle. To this end, we first 
characterized circadian rhythms in ApoE-/- mice. We chose to study ApoE-/- mice because 
they spontaneously develop atherosclerosis196. Next, we sought to determine whether 
circadian disruption with constant light exposure increased atherosclerosis in ApoE-/- 
mice. 
 
Results 
Circadian behavioral rhythms are similar in ApoE+/+ and ApoE-/- mice 
We first characterized daily and circadian wheel-running activity rhythms in 
C57BL/6J ApoE-/- mice. We found that ApoE-/- mice had daily rhythms of wheel-running 
activity in 12h light:12h dark (12L:12D) that were indistinguishable from ApoE+/+ mice 
(Fig. 1a, b; actograms of all individual mice shown in Figs. S1, S2). The amplitude of the 
wheel-running activity rhythm was not significantly different in ApoE-/- and ApoE+/+ 
mice in 12L:12D (Fig. 1c, 1d, Table S1, t-test p=0.21). There was no significant 
difference between ApoE-/- and ApoE+/+ mice in daily activity levels in 12L:12D (Fig. 
S3a, Table S1, t-test p=0.99). 
 We next released the mice into constant darkness to measure circadian behavior 
rhythms. We found that the phase angle of entrainment to the light-dark cycle was the 
same in ApoE-/- and ApoE+/+ mice (Fig. 1e, Mann-Whitney p=0.24). In constant darkness, 
the free-running period of wheel-running activity did not significantly differ between 
ApoE+/+ and ApoE-/- mice (Fig. 1f, Table S1, t-test p=0.08). The amplitude of the activity 
rhythm (Fig. S3d, t-test p=0.03) and the daily activity level (Fig. S3b, t-test p=0.05) were 
slightly decreased in ApoE-/- mice in constant darkness (Table S1).  
 We next measured circadian behavior rhythms during the first 7 days in constant 
light (Fig. S4; actograms of all individual mice shown in Fig. S5). The free-running 
periods (Fig. S4c, Mann-Whitney p=0.29) and amplitudes (Fig. S4d, t-test p=0.46) of the 
wheel-running activity rhythms in constant light did not significantly differ between 
ApoE+/+ and ApoE-/- mice (Table S1). The daily activity level in constant light was also 
similar between ApoE+/+ and ApoE-/- mice (Fig. S3c, Table S1, t-test p=0.92).  
 
Phase responses to light pulses are not altered in ApoE-/- mice 
The phases (or timing) of circadian locomotor activity rhythms in C57BL/6J mice 
shift in response to light exposure at certain times of day248. Light exposure during the 
early subjective night at circadian time (CT) 14-16 delays the phase, while light during 
the late subjective night (CT21-23) advances the phase of the activity rhythm248,249. On 
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the other hand, light during the subjective day (CT1-11) has no effect on the phase of the 
activity rhythm248,249. This light responsiveness is how the SCN entrains to the light-dark 
cycle and how the SCN adjusts to changes in the light-dark cycle (such as after travel to a 
new time zone). Thus, we next tested the phase responses to light pulses in ApoE-/- mice. 
We housed ApoE-/- and ApoE+/+ mice in constant darkness and then administered a single 
15-min light pulse at either CT8-10, CT14-16, or CT21-23 (Fig. 2, light pulses for all 
individual mice are shown in Figs. S6, S7, S8). There were no significant differences in 
the magnitudes of the phase responses to light pulses between ApoE-/- and ApoE+/+ mice 
at any phase (Table S1). Neither genotype had phase responses to light pulses at CT8-10 
(t-test p=0.94), and both genotypes phase-delayed to light pulses at CT14-16 (t-test 
p=0.64) and phase-advanced to light pulses at CT21-23 (Mann-Whitney p=0.16). These 
data demonstrate that ApoE-/- mice have circadian light responsiveness that is 
indistinguishable from ApoE+/+ mice.  
 
Molecular timekeeping rhythms and circadian organization are not altered in ApoE-
/- mice 
We next measured the effect of ApoE-deficiency on the molecular timekeeping 
mechanism by measuring bioluminescence from tissues cultured from male and female 
ApoE+/+ and ApoE-/- mice with the PERIOD2::LUCIFERASE reporter71 (Fig. 3, Fig. S9, 
Table S2). We analyzed tissues from ApoE-/- mice at 8 and 20 weeks old because ApoE-/- 
mice spontaneously develop atherosclerosis at ~12 weeks old, and we could therefore 
analyze tissue rhythms before and after development of atherosclerosis197. The periods of 
the PER2::LUC rhythms in SCN (p=0.10), liver (p=0.76), pituitary (p=0.25), lung 
(p=0.88), kidney (p=0.51), aorta (p=0.38), spleen (p=0.68), and white adipose tissue 
(p=0.66) did not differ significantly between 8-week old ApoE+/+ mice and ApoE-/- mice 
at 8 and 20 weeks old (one-way ANOVA; Fig. 3a, Table S2). Likewise, we found that the 
phases of the SCN (p=0.54), liver (p=0.87), pituitary (p=0.36), lung (p=0.15), kidney 
(p=0.59), aorta (p=0.62), spleen (p=0.41), and white adipose tissue (p=0.73) were not 
significantly different between ApoE+/+ and ApoE-/- mice at 8 and 20 weeks old (one-way 
ANOVA, Fig. 3b, Table S2). The amplitudes of the tissue PER2::LUC rhythms ware also 
similar between 8-week old ApoE+/+ mice and ApoE-/- mice at 8 and 20 weeks old (Table 
S2). These data demonstrate that the molecular timekeeping mechanism is not altered by 
ApoE deficiency.  
 
Exposure to constant light exacerbates atherosclerosis in male ApoE-/- mice 
We next investigated the effects of chronic exposure to constant light on 
atherosclerosis (Fig. 4, Table S3). Similar to previous studies in wild-type mice, 
locomotor activity was arrhythmic or the rhythm was disrupted in ApoE-/- mice housed in 
constant light (Fig. 4b, actograms of all individual mice shown in Figs. S10, S11, S12, 
S13; Fig. S14)250. Male (Fig. 4c, t-test p=0.001), but not female (Fig. 4e, Mann-Whitney 
p=0.08) ApoE-/- mice housed in constant light had more atherosclerosis in the en face 
aorta compared to those in control 12L:12D (Table S3). Likewise, atherosclerotic lesion 
area in the aortic root was increased in male (Fig. 4d, Mann-Whitney p=0.04), but not in 
female (Fig. 4f, t-test p=0.20), ApoE-/- mice exposed to constant light (Table S3). 
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Constant light exposure exacerbates dyslipidemia, but not inflammation in male 
ApoE-/- mice 
We next examined the potential mechanisms by which exposure to constant light 
could increase atherosclerosis in male ApoE-/- mice. Male ApoE-/- mice had similar body 
weights (t-test p=0.13) and calorie consumption (t-test p=0.52) in 12L:12D and constant 
light, although the mice were less active in constant light (Mann-Whitney p=0.008) 
(Table S4). 
Male ApoE-/- mice housed in constant light had increased total serum cholesterol 
concentrations (Fig. 5a, Mann-Whitney p=0.009), due to increased VLDL/LDL particles 
(Fig. 5b), compared to males in control 12L:12D. There was no significant difference in 
total serum cholesterol concentrations (Fig. S15a, t-test p=0.47) or in the distribution of 
cholesterol on lipoproteins (Fig. S15b) in female ApoE-/- mice housed in control 12L:12D 
compared to constant light (Table S3). Exposure to constant light did not significantly 
alter total serum triglycerides concentrations in male (Fig. S16a, Mann-Whitney p=0.07) 
or female ApoE-/- mice (Fig. S16b, t-test p=0.40) (Table S3). 
We next measured macrophages in the vascular wall of aortic roots as a marker of 
inflammation (Fig. 6). The percent macrophage content of the lesions in aortic roots was 
not altered by constant light exposure in male ApoE-/- mice compared to mice in 12L:12D 
(Fig. 6c, t-test p=0.62, Table S3). 
 
Discussion 
ApoE-/- mice are a well-established rodent model for studying atherosclerosis198. 
Beginning at ~12 weeks of age, male and female ApoE-/- mice spontaneously develop 
atherosclerotic lesions in the aorta, even when fed a low-fat (non-Western) diet197. It was 
critical to our experimental design to use a mouse model that develops atherosclerosis on 
low-fat diet. This is because diet-induced obesity increases atherosclerosis in ApoE-/- mice 
and high-fat diet feeding disrupts daily rhythms in male wild-type mice251,252. Therefore, 
in this study, we sought to exclude the potential confounding effects of high-fat diet 
feeding on atherosclerosis and circadian rhythms in order to isolate the effects of constant 
light-induced circadian disruption. To this end, we fed ApoE-/- mice a low-fat diet for the 
duration of the study. This protocol prevented hyperphagia and obesity in male ApoE-/- 
mice. Thus, the exacerbation of atherosclerosis in male ApoE-/- mice housed in constant 
light occurred independently of systemic metabolic dysfunction caused by obesity.  
 The first goal of this study was to determine if ApoE-/- mice are an appropriate 
model for studying the effects of light-induced circadian disruption on atherosclerosis. 
An ideal model should have no inherent circadian rhythm abnormalities. One previous 
study found that ApoE-/- mice had unstable activity rhythms in constant darkness and 
impaired circadian responsiveness to light253. Therefore, we first comprehensively 
characterized circadian rhythms of behavior and light responsiveness, and molecular 
circadian rhythms in tissues in ApoE-/- mice. We found that ApoE-/- mice were 
indistinguishable from ApoE+/+ mice in every parameter measured, with the exception of 
slight significant reductions in total activity and amplitude in ApoE-/- mice in constant 
darkness. Endogenous (free-running) and entrained rhythms of wheel-running activity, as 
well as responsiveness to light pulses at different times of day were the same in ApoE-/- 
and ApoE+/+ mice. Moreover, the molecular timekeeping rhythms in the SCN and 
peripheral tissues, as well as the phase relationship between these body clocks, were the 
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same in ApoE-/- and ApoE+/+ mice. We postulate that our results differ from the previous 
study because the ApoE-/- mice used in the prior study may have been on a mixed genetic 
background while the ApoE-/- mice in our study were backcrossed 10 times into a 
C57BL/6J background. Genetic background markedly affects circadian activity rhythms 
in mice and the C57BL/6J strain has stable, high-amplitude behavior rhythms254. In sum, 
we found that ApoE-/- mice have no circadian abnormalities and thus are an ideal model 
for studying the effects of light-induced circadian disruption on atherosclerosis. 
The second goal of this study was to investigate the effects of constant light 
exposure, which chronically disrupts circadian rhythms, on atherosclerosis. Most 
previous studies investigated the effects of circadian disruption on atherosclerosis using 
circadian gene mutant mice218,219,221,224,238. To our knowledge, only two studies have 
examined the effects of light-induced circadian disruption on atherosclerosis in mice. One 
study inferred that a weekly inversion of the light-dark cycle accelerated atherosclerosis 
development in ApoE-/- mice, but lacked quantitative data226. A second study recently 
showed that weekly inversion of the light-dark cycle increased severe atherosclerotic 
lesions in female APOE*3-Leiden.CETP mice due to increased macrophage content and 
inflammatory, oxidative stress, and chemoattraction markers in the vascular walls255. 
However, the data from the present study demonstrate that the observed increase in 
atherosclerosis in male ApoE-/- mice exposed to constant light was driven by increased 
VLDL/LDL cholesterol rather than increased macrophage content. Additionally, the mice 
in the previous study were fed a Western diet (high fat and high cholesterol), which 
independently causes metabolic dysfunction, obesity and disrupts circadian 
rhythms245,256-261. Therefore, our study is unique in that we found that disordered light 
exposure exacerbates atherosclerosis even when mice are fed low-fat diet. An additional 
strength of our study is that we studied both male and female ApoE-/- mice, while only 
females could be studied in the previous study because male APOE*3 Leiden.CETP mice 
do not develop atherosclerosis on a cholesterol-rich diet.  
In mice, constant light exposure increases the period of activity rhythms and, 
chronically, can cause arrhythmicity262. At the tissue level, constant light desynchronizes 
cellular oscillators in the SCN, causing the overall rhythm of the SCN to be low-
amplitude or absent250. Since the SCN is the master circadian clock that coordinates 
physiological and behavioral rhythms throughout the body, the effect of constant light 
exposure on the SCN results in whole-body disruption of circadian rhythms87,250. 
Previous studies showed that constant light exposure increased body weight, disrupted 
insulin sensitivity, and decreased triglyceride-derived fatty acids and glucose uptake by 
brown adipose tissue263-265. However, no study has examined the effects of constant light 
exposure on atherosclerosis. In the current study, we found that exposure to constant light 
increased cholesterol on atherogenic lipoproteins and atherosclerotic lesion area in male 
ApoE-/- mice. According to the lipid hypothesis, chronic elevated levels of cholesterol in 
the blood causes atherosclerosis266-268. In female ApoE-/- mice, constant light exposure did 
not increase total or VLDL/LDL-cholesterol concentrations nor atherosclerotic lesion 
area. The mechanisms underlying the sex difference in response of lipids to light-induced 
circadian disruption are unknown but could be due to differences in circulating sex 
hormones. 
In sum, we found that ApoE-/- mice had circadian rhythms that were 
indistinguishable from ApoE+/+ mice. In addition, circadian disruption with constant light 
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exposure increased atherosclerosis in male, but not female ApoE-/- mice. Together these 
data establish male ApoE-/- mice as an appropriate model for studying the effects of light-
induced disruption of circadian rhythms on atherosclerosis. 
 
Methods 
Animals 
C57BL/6J ApoE-/- (N10) mice were purchased from The Jackson Laboratory 
(stock # 002052) and bred with wild-type C57BL/6J mice (from The Jackson Laboratory) 
to generate C57BL/6J heterozygous ApoE+/- mice. Heterozygous C57BL/6J ApoE+/- 
males and females were bred to generate ApoE+/+ and ApoE-/- mice (N11-N12) for 
experiments. For bioluminescence experiments, ApoE+/- mice that were heterozygous for 
PERIOD2::LUCIFERASE71 (originally obtained from Dr. Joseph Takahashi and then 
backcrossed for 25 generations with C57BL/6J mice from The Jackson Laboratory) were 
crossed with ApoE+/- mice to generate ApoE+/+ and ApoE-/- mice that were heterozygous 
for PER2::LUC for experiments. Breeders and weanlings were housed in 12L:12D and 
fed standard rodent laboratory diet (Teklad 2918) and water ad libitum. At 3 weeks old, 
offspring were weaned and group-housed with same-sex siblings. Genotyping for ApoE-/- 
was performed according to the protocol on The Jackson Laboratory website. Genotyping 
for PER2::LUC was determined by measuring bioluminescence from tail snips. For all 
experiments, mice were singly-housed in cages (33 cm x 17 cm x 14 cm) with running 
wheels (diameter: 11cm) and fed low-fat diet (Research Diets D12450K, 10% kcal fat) 
and water ad libitum. The running wheels were either unlocked (could rotate) or locked 
(could not rotate), as indicated for each specific experiment below. All procedures were 
conducted in accordance with animal protocol 2015-2211 approved by the University of 
Kentucky Institutional Animal Care and Use Committee. 
 
Characterization of circadian behavior  
At 7 to 8 weeks old, male and female ApoE-/- and ApoE+/+ mice were housed 
singly in cages with unlocked running wheels. The cages were placed in light-tight boxes 
in 12L:12D with white LED lights (intensity 250 to 350 lux). Wheel revolutions were 
recorded every minute using the ClockLab system (Actimetrics, Inc, Wilmette, IL). Mice 
were housed in 12L:12D for 7 days and then in constant darkness for 7 days. Data were 
analyzed with ClockLab analysis software (Actimetrics). Mean activity profiles of wheel-
running activity (5-min bins) were compiled for7 days in 12L:12D. The amplitude (Qp) of 
the wheel-running rhythm was the peak value of the 2 periodogram for 7 days in 
12L:12D or 7 days in constant darkness or 7 days in constant light. Mean daily activity 
was determined for 7 days in 12L:12D or 7 days in constant darkness or 7 days in 
constant light. The phase angle of entrainment was determined by fitting a linear 
regression line to 5 days in constant darkness, and then extending it back to the last day in 
12L:12D. The free-running period of wheel-running activity in constant darkness was 
determined by 2 periodogram with alpha set to 0.001 for days 1-7 in constant darkness. 
After 18 days in constant darkness with weekly light pulses (see below), we returned the 
mice to 12L:12D for 20 days and then released them into constant light for 21 days. The 
free-running period of wheel-running activity in constant light was determined by 2 
periodogram for days 1-7 in constant light.  Wheel-running activity data are shown in 
actograms in 6-min bins in the normalized format (ClockLab).  
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Circadian phase responses to light pulses 
Male and female ApoE+/+ and ApoE-/- mice (12-18 weeks old at time of light 
pulse) were single housed in cages with ad libitum access to unlocked running wheels. 
The cages were housed in light-tight boxes in 12L:12D with white LED lights (intensity 
250 to 350 lux). Mice were then released into constant darkness for 7 days. The onset of 
activity on the day of the light pulse, which was designated as CT12, was determined by 
linear regression using ClockLab Analysis. A single light pulse (15min, 150 lux white 
LED) was administered at CT8-10 (subjective day), or CT14-16 (early subjective night), 
or CT21-23 (late subjective night). The mice then free-ran for 7 days after the light pulse. 
The magnitudes of the phase shifts were determined by measuring the time between a 
line fit to the onset of activity the 7 days before the light pulse and a line fit to the onset 
of activity the 7 days after the light pulse using ClockLab Analysis software. Some mice 
were administered more than 1 light pulse, every 3 weeks, and the cages were changed in 
the week between pulses. Each mouse received no more than 3 light pulses and an 
individual mouse never received a light pulse at the same CT.  
 
Bioluminescence tissue rhythms 
Male and female ApoE-/- and ApoE+/+ mice (7 weeks old) that were heterozygous 
for PER2::LUC were housed singly in cages with locked wheels (wheels were present but 
could not rotate) in 12L:12D. At 8 or 20 weeks old, mice were euthanized by cervical 
dislocation without anesthesia and aorta, kidney, lung, liver, pituitary, spleen, SCN, and 
white adipose tissue explants were dissected and cultured as described previously269. 
Bioluminescence was measured every 10 min with the 32-channel LumiCycle apparatus 
(Actimetrics Inc.). Data were smoothed by 30-min adjacent averaging and detrended 
using LumiCycle Analysis software (Actimetrics Inc.). The amplitude (goodness of fit 
≥90%) was determined from the cycle that occurred between 12-36 hours in culture with 
LumiCycle Analysis software (Actimetrics). The data were exported to ClockLab 
analysis software to analyze period and phase. The period was determined from a 
regression line fit to the acrophase of 3-5 cycles. The phase was the acrophase of the peak 
of bioluminescence that occurred between 12-36 hours in culture.  
 
Effects of constant light exposure on atherosclerosis, lipids, and inflammation  
At 7 weeks old, male and female ApoE-/- mice were single-housed in cages with 
locked running wheels in light-tight boxes in 12L:12D. General locomotor activity was 
continuously recorded with passive infrared sensors and collected in one-minute intervals 
using the ClockLab acquisition system (Actimetrics Inc.). At 8 weeks old, mice were 
randomized to either remain in 12L:12D or to be housed in constant light for 12 weeks. 
Body and food weights were measured weekly between ZT9-ZT12, where ZT0 is lights 
on and ZT12 is lights off, in 12L:12D, or the corresponding local time for mice in 
constant light. 2 periodograms were used to determine whether general locomotor 
activity was rhythmic in the final 28 days in constant light using ClockLab analysis 
software. Activity was rhythmic if a dominant peak exceeded alpha set at p=0.001 
(period range 20-36h). 
 At 20 weeks of age, mice were anesthetized with inhaled isoflurane between ZT6-
9 (or the corresponding local time for mice in constant light) until unresponsive to toe 
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pinches, then euthanized by cervical dislocation. Blood was collected by cardiac puncture 
and serum was separated by centrifugation and stored at -80°C. The aortas were perfused 
with NaCl (0.9% wt/vol) via left ventricular puncture. Aortas were dissected from the 
root to the iliac bifurcation as described previously270. The heart was removed from the 
aorta and stored at -80°C. Mice with gross organ abnormalities were excluded from the 
study (2 mice from the female constant light group were excluded for enlarged kidneys). 
The aortas were stored in 10% neutrally-buffered formalin for 24-hours at room 
temperature and then transferred to 0.9% NaCl solution and stored at room temperature.  
 To measure atherosclerotic lesion area in en face aortas, peri-aorta adipose tissue 
was removed and the aorta was cut longitudinally and photographed using Image-Pro 7.0 
software. The aortic arch was defined as the ascending arch to 3 mm distal to the root of 
the left subclavian artery. Atherosclerotic lesion area of the aortic arch was measured 
using Image-Pro 7.0 software by one researcher not blinded to the experimental 
treatments and analyzed by a second researcher who was blinded to the experimental 
groups.  
 Atherosclerotic lesion area in the aortic root was measured as described 
previously270. Briefly, 9 serial tissue sections (10 µm) from the origin of the aortic valves 
to the ascending aorta, were stained with oil red O. Serial sections were distributed 
among eight consecutive slides resulting in ~80µm intervals for each slide. Lesions were 
quantified from the internal elastic lamina to the luminal edge using Image-Pro 7.0 
software by 2 researchers as described above. 
 
Lipid analysis 
Total serum cholesterol (Cholesterol E Enzymatic Kit, Wako Pure Chemical 
Industries kits Mountain View, CA) and triglycerides concentrations (L-Type 
Triglyceride M Enzyme Color A and Color B, Wako Pure Chemical Industries kits 
Mountain View, CA) were analyzed. Lipoprotein cholesterol and triglyceride 
distributions were analyzed from individual serum samples (50 µl) fractioned by fast 
protein liquid chromatography (FPLC) (Leica CM1860). Fractions were collected and 
cholesterol and triglyceride concentrations were determined with the Wako kits described 
above. For each group, 4-5 samples around the mean total serum cholesterol 
concentration were analyzed.  
 
Macrophage quantification 
Immunohistochemistry for macrophages was performed on frozen serial sections 
(adjacent to those stained with Oil Red O) of the ascending aorta using the MicroProbe 
system as described previously using rat anti-mouse CD68 (Bio-Rad, Cat# MCA1957), 
Rat IgG2b (BD PharMingen, Cat# 559478), and biotinylated rabbit anti-rat IgG (Vector, 
Cat# BA-4001) antibodies271. Immunoreactivity was visualized with red chromogen 3-
amino-9-ethylcarbazole (AEC) (Vector). Macrophage content was quantified in the first 
serial section of the aortic root from the internal elastic lamina to the luminal edge using 
Image-Pro 7.0 software by 2 researchers as described above. The area of CD68 staining 
was expressed as a percentage of atherosclerotic lesion area.  
 
Statistical analyses 
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A priori power analyses were performed for circadian behavior parameters and en 
face atherosclerotic lesion area using alpha=0.05, power=0.80, and effect size of 1 to 1.5 
using G*Power (Heinrich Heine Universität Düsseldorf) (Table S5). Circadian behavior 
parameters (amplitude, daily activity, phase angle of entrainment, period) and phase 
shifts in response to light pulses at each CT were compared between ApoE+/+ and ApoE-/- 
mice using two-tailed Student’s t-tests, unless the data were not normally distributed or 
had unequal variance, in which case the Mann-Whitney test was used. One-way 
ANOVAs were used to compare the phase of the bioluminescence rhythm of each tissue 
among groups. Atherosclerosis lesion area in the en face aorta and aortic roots, total 
serum cholesterol and triglyceride concentrations, cumulative food intake, cumulative 
locomotor activity, and the percentage of lesions with macrophages in ApoE-/- mice of the 
same sex were compared between 12L:12D and constant light conditions using two-tailed 
Student’s t-tests, unless the data were not normally distributed or had unequal variance, 
in which case the Mann-Whitney test was used. Statistical tests were performed with 
OriginPro 2016 (Northampton, MA). Data are presented as the mean ± SEM. 
Significance was ascribed at p<0.05. 
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Figures 
k 
Figure 1. Circadian behavior rhythms in ApoE-/- mice are indistinguishable from 
ApoE+/+ mice.  
Representative single-plotted actograms of wheel-running activity of ApoE+/+ (a) and 
ApoE-/- (b) mice housed in 12L:12D for 7 days (LD) and then released into constant 
darkness for 7 days (DD). Yellow shading shows lights on. Mean activity profiles (c) 
were generated from 7 days in 12L:12D. The amplitudes in LD (d) were the peak Qp’s of 
the 2 periodograms for 7 days in 12L:12D. The phase angles of entrainment (e) were 
determined by drawing a regression line to activity onset for days 1-5 in constant 
darkness and then extending the line to the last day in 12L:12D. A positive phase angle 
occurred when activity started after the time of lights off. The free-running period (f) was 
determined using a 2 periodogram for days 1-7 in constant darkness. There were no 
significant differences between ApoE+/+ and ApoE-/- mice. Data are mean ± SEM. 
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Figure 2. Phase response to light pulses do not differ between ApoE+/+ and ApoE-/- 
mice.  
Representative actograms of ApoE+/+ (a-c) and ApoE-/- (d-f) mice administered a single 
15-min light pulse (indicated by yellow box) at circadian time (CT) 8-10 (subjective day), 
14-16 (early subjective night), or 21-23 (late subjective night) in constant darkness (x-
axis: hours; y-axis: days). There were no significant differences between ApoE+/+ and 
ApoE-/- mice (g). Data are mean ± SEM. 
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Figure 3. Molecular timekeeping rhythms in tissues are not altered in ApoE-/- mice. 
Tissues were cultured from ApoE+/+ mice at 8 weeks old (light gray), ApoE-/- mice at 8 
weeks old (dark gray), and ApoE-/- mice at 20 weeks old (blue) mice. The phases (mean ± 
SEM) were determined from the peaks of PER2::LUC expression during the interval 
between 12 and 36h in culture and plotted relative to the last lights on. The white bar 
indicates lights on and black bar indicates lights off. SCN: suprachiasmatic nuclei; WAT: 
white adipose tissue. n=5-10/tissue/group. There were no significant differences between 
ApoE+/+ and ApoE-/- mice. Data are mean ± SEM. 
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Figure 4. Constant light exposure exacerbates atherosclerosis in male ApoE-/- mice. 
Representative single-plotted actograms of general locomotor activity of male ApoE-/- 
mice housed in control 12L:12D (a) or constant light (b) for 12 weeks. Yellow shading 
shows lights on. Percent atherosclerotic lesion area in en face aortas (c, e) and mean 
lesion area of aortic roots (d, f) of male (c, d) and female (e, f) ApoE-/- mice housed in 
control 12L:12D (black symbols) or constant light (red symbols) for 12 weeks. Data from 
individual mice are closed symbols and open symbols are mean ± SEM (c-f). *p<0.05, 
**p=0.001. 
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Figure 5. Constant light exposure increases VLDL/LDL-cholesterol concentrations 
in male ApoE-/- mice. 
Total serum cholesterol concentrations (a: individual mice are closed symbols and open 
symbols are mean ± SEM) and distribution of cholesterol on lipoproteins (b: mean ± 
SEM, FPLC was performed on n=4-5/group) of male ApoE-/- mice housed in control 
12L:12D (black) or constant light (red) for 12 weeks. **p=0.009. 
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Figure 6. Constant light exposure does not increase macrophages in atherosclerotic 
lesions in aortic roots of male ApoE-/- mice. 
Representative CD68 immunostaining of aortic roots (a, b) and percent of atherosclerotic 
lesions with CD68 staining (c) from male ApoE-/- mice housed in control 12L:12D (a, 
black symbols) or constant light (b, red symbols) for 12 weeks. Data from individual 
mice are closed symbols and open symbols are mean ± SEM (c). There was no significant 
difference between ApoE+/+ and ApoE-/- male mice. 
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Supplementary Tables 
 
Table S1. Descriptive statistics and statistical analyses of circadian behavior. 
Circadian behavior 
parameter 
ApoE+/+         
mean ± SEM (n) 
ApoE-/-          
mean ± SEM (n) 
Test* 
Test 
statistic,  
p value 
Activity in 12L:12D#     
Amplitude (Qp) 1165 ± 42 (13) 1099 ± 29 (13) t-test 
t24=1.29, 
p=0.21 
Daily Activity (wheel rev x 
103) 
26.3±1.6 (13) 26.3±1.5 (13) t-test 
t24=-
0.002, 
p=0.99 
Phase Angle of Entrainment 
(h) 
0.34 ± 0.08 (13) 0.47 ± 0.09 (13) 
Mann-
Whitney 
U=61, 
p=0.24 
Activity in Constant 
Darkness^ 
    
Period (h) 23.73 ± 0.03 (13) 23.80 ± 0.02 (13) t-test 
t24=-1.85, 
p=0.08 
Amplitude (Qp) 1385 ± 34 (13) 1295 ± 22 (13) t-test 
t24=2.24, 
p=0.03 
Daily Activity (wheel rev x 
103) 
37.8 ± 1.7 (13) 32.9 ± 1.8 (13) t-test 
t24=2.03, 
p=0.05 
Activity in Constant Light&     
Period (h) 25.44 ±0.16 (5) 25.05 ± 0.20 (5) 
Mann-
Whitney 
U=18, 
p=0.29 
Amplitude (Qp) 659 ± 99 (5) 570 ± 60 (5) t-test 
t8=0.77, 
p=0.46 
Daily Activity (wheel rev x 
103) 
9.9 ± 2.7 (5) 9.5 ± 2.0 (5) t-test 
t8=0.11, 
p=0.92 
Light Responsiveness     
Circadian time 8-10 -0.02± 0.23 (4) 0.01±0.15 (4) t-test 
t6=-0.08, 
p=0.94 
Circadian time 14-16 -1.95±0.24 (6) -2.12±0.24 (8) t-test 
t12=0.48, 
p=0.64 
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Circadian time 21-23 1.01±0.27 (4) 0.64±0.16 (7) 
Mann-
Whitney 
U=22, 
p=0.16 
*Tests are two-tailed; #7 days in 12L:12D; ^Days 1-7 in constant darkness; &Days 1-7 in 
constant light 
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Table S2. Circadian parameters of bioluminescence rhythms in ex vivo tissues. 
Circadian 
parameter 
Tissue 
ApoE+/+ 
8 weeks old 
(n) 
ApoE-/- 
8 weeks old 
(n) 
ApoE-/- 
20 weeks old 
(n) 
One-way 
ANOVA 
Period (h) 
SCN 
 24.1 ± 0.1 
(11) 
24.4 ± 0.1 (8) 24.3 ± 0.1 (5) F(2,21)= 2.6, p=0.10 
Liver 21.0 ± 0.4 (6) 21.1 ± 0.3 (7) 20.7 ± 0.1 (5) F(2,15)=0.27,p=0.76  
Pituitary 23.1 ± 0.2 (10) 23.4 ± 0.1 (8) 23.6 ± 0.3 (7) 
F(2,22)=1.48, 
p=0.25 
Lung 23.3 ± 0.3 (10) 23.3 ± 0.3 (5) 23.5 ± 0.2 (6) 
F(2,18)=0.12, 
p=0.88 
Kidney 25.1 ± 0.2 (10) 24.7 ± 0.2 (5) 25.0 ± 0.2 (7) 
F(2,19)=0.69, 
p=0.51 
Aorta 22.7 ± 0.3 (9) 23.4 ± 0.3 (5) 23.1 ± 0.4 (7) 
F(2,18)=1.03, 
p=0.38 
Spleen 23.6 ± 0.3 (9) 23.1 ± 0.5 (4) 23.2 ± 0.7 (5) 
F(2,15)=0.39, 
p=0.68 
WAT 26.2 ± 0.4 (6) 26.2 ± 0.2 (5) 26.6 ± 0.2 (3) 
F(2,11)=0.43, 
p=0.66 
Amplitude 
(counts/s) 
SCN 96.6 ± 6.6 (11) 
91.5 ±1 9.4 
(9) 
96.5 ±15.2 
(5) 
F(2,22)=0.10, 
p=0.90 
Liver 21.2 ± 3.8 (9) 
19.3 ± 3.0 
(10) 
23.9 ± 5.1 (6) 
F(2,22)=0.33, 
p=0.72 
Pituitary 
119.7 ± 13.7 
(10) 
124 ± 17.7 (8) 
104.7 ± 15.2 
(7) 
F(2,22)=0.38, 
p=0.69 
Lung 21.3 ± 6.7 (9) 
25.0 ± 84.6 
(6) 
21.9 ± 4.3(6) 
F(2,18)= 0.17, 
p=0.84 
Kidney 6.1 ± 1.0 (8) 6.5 ± 1.6 (8) 6.4 ± 1.1 (7) 
F(2,20)= 0.02, 
p=0.98 
Aorta 28.3 ± 8.9 (9) 29.2 ± 5.3 (8) 21.1 ± 3.6 (6) 
F(2,20)= 0.34, 
p=0.71 
Spleen 20.7 ± 3.1 (9) 30.9 ± 5.6 (7) 21.9 ± 5.3 (6) 
F(2,19)=1.54, 
p=0.24 
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WAT 11.27 ± 6.3 (6) 
15.81±7.03 
(3) 
ND t8= 0.54, p=0.61# 
Phase      
(h after 
lights on) 
SCN 35.7 ± 0.4 (11) 35.7±0.3 (9) 36.3 ± 0.4 (6) 
F(2,23)=0.64, 
p=0.54 
Liver 37.5 ± 0.5 (11) 
37.3 ± 0.4 
(10) 
37.9 ± 0.4 (5) 
F(2,23)=0.14, 
p=0.87 
Pituitary 38.6 ± 0.2 (10) 38.4 ± 0.3 (9) 37.9 ± 0.5 (7) 
F(2,23)=1.08, 
p=0.36 
Lung 40.4 ± 0.5 (12) 40.6 ± 0.4 (7) 41.9 ± 0.3 (6) 
F(2,22)=2.09, 
p=0.15 
Kidney 41.3 ± 0.3 (12) 41.3 ± 0.3 (9) 41.7 ± 0.4 (7) 
F(2,25)=0.54, 
p=0.59 
Aorta 42.8 ± 0.6 (10) 42.2 ± 0.4 (8) 42.9 ± 0.5 (7) 
F(2,22)=0.48, 
p=0.62 
Spleen 43.9 ± 0.5 (9) 43.3 ± 0.6 (7) 44.4 ± 0.5 (6) 
F(2,19)=0.94, 
p=0.41 
WAT 45.5 ± 0.8 (6) 45.5 ± 0.7 (7) 44.6 ± 0.7 (3) 
F(2,13)=0.33, 
p=0.73 
Data are mean ± SEM 
ND: not determined because goodness of fit was less than 90% for most samples in this 
group. 
#Groups were compared using two-tailed Student’s t-test 
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Table S3. Descriptive statistics and statistical analyses of atherosclerosis and lipids. 
 
Control 12L:12D  
mean ± SEM (n) 
Constant light 
mean ± SEM (n) 
Test* 
Test statistic, 
 p value 
En face lesion area 
(% of arch) 
    
Males 2.97 ± 0.39 (19) 5.67 ± 0.69 (16) t-test 
t33=-3.56, 
p=0.001 
Females 2.69 ± 0.41 (18) 3.61 ± 0.42 (21) 
Mann-
Whitney 
U=127, p=0.08 
Lesion area of aorta 
roots (mm2) 
    
Males  0.05 ± 0.01 (9) 0.09 ± 0.02 (9) 
Mann-
Whitney 
U=17, p=0.04 
Females 0.10 ± 0.03 (7) 0.16 ± 0.03 (14) t-test 
t19=-1.32, 
p=0.20 
Total serum 
cholesterol (mg/dl) 
    
Males  629.0 ± 33.3 (19) 804.6 ± 52.9 (16) 
Mann-
Whitney 
U=73, p = 0.009 
Females 415.9 ± 18.8 (18) 436.1 ± 20.1 (21) t-test 
t37=-0.73, p = 
0.47 
Total serum 
triglycerides (mg/dl) 
    
Males  98.5 ± 11.7 (19) 127.7 ± 15.5 (16) 
Mann-
Whitney 
U=96, p=0.07 
Females 39.8 ± 4.4 (18) 35.2 ± 3.2 (21) t-test t37=0.86, p=0.40 
Macrophages (% 
lesion area) 
    
Males 66.4 ± 8.3 (9) 72.0 ± 7.4 (9) t-test 
t16=-0.51, 
p=0.62 
Females Not determined Not determined - - 
Comparisons were made within the same sex for each parameter; *Tests are two-tailed 
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Table S4. Descriptive statistics and statistical analyses of metabolic parameters. 
Metabolic Parameter 
Control 
12L:12D mean ± 
SEM (n) 
Constant light 
mean ± SEM (n) 
Test* 
Test statistic,  
p value 
Body weight (beginning, g)      
Males 23.9 ± 0.6 (19) 24.9 ± 0.4 (16) t-test 
t33=-1.56, 
p=0.13 
Females 18.5 ± 0.3 (18) 18.5 ± 0.3 (21) t-test 
t37=-0.03, 
p=0.98 
Body weight (ending, g)     
Males 29.5 ± 0.9 (19) 31.6 ± 1.1 (16) t-test 
t33=-1.53, 
p=0.14 
Females 22.2 ± 0.3 (18) 23.6 ± 0.3 (21) t-test 
t37=-2.95, 
p=0.005 
Cumulative food intake (g)     
Males 287.1 ± 5.2 (19) 282.3 ± 5.0 (16) t-test 
t33=0.66, 
jcp=0.52 
Females 271.3 ± 3.7 (18) 247.6 ± 2.8 (21) t-test 
t37=5.21, 
p<0.001 
Cumulative activity (x103 
cts) 
    
Males 
181.6 ± 10.5 
(18^) 
137.5 ± 9.8 (16) 
Mann-
Whitney 
U=221, 
p=0.008 
Females 214.5 ± 7.6 (18) 
161.3 ± 10.1 
(20^) 
Mann-
Whitney 
U=295, 
p<0.001 
Comparisons were made within the same sex for each parameter; 
*Tests are two-tailed; 
^1 mouse was removed from the activity analysis due to faulty infrared sensor 
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Table S5. A priori power analyses to compute required sample sizes^ 
Parameter 
Difference 
in means 
Standard 
deviation* 
Effect 
size 
Required 
sample 
size  
Actual 
sample size 
Activity in 12L:12D*      
Amplitude (Qp) 638 424 1.5 n=9/grp n=13/grp 
Phase Angle of Entrainment 
(h)* 
0.47 0.31 1.5 n=8/grp n=13/grp 
Activity in Constant 
Darkness* 
     
Period (h) 0.3 0.21 1.5 n=9/grp n=13/grp 
Amplitude (Qp) 638 424 1.5 n=9/grp n=13/grp 
Activity in Constant Light*      
Period (h) 0.57 0.38 1.5 n=9/grp n=5/grp 
Amplitude (Qp) 115 78 1.5 n=9/grp n=5/grp 
Light Responsiveness*      
Circadian time 14-16 (h) 0.62 0.41 1.5 n=8/grp n=6-8/grp 
En face lesion area# (% of 
arch) 
0.94 0.91 1.0 n=16/grp 
n=16-
21/grp 
^Power analyses were performed with alpha=0.05 and power=0.80 for unpaired, two-
tailed t-tests. The effect size used for each analysis is indicated. 
*Means and standard deviations were from our previous studies of wheel-running activity 
and PER2::LUC tissue rhythms in C57BL/6J mice249,272 
*Means and standard deviations were from our pilot studies in ApoE-/- mice fed 10% kcal 
low-fat diet for 12 weeks. 
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Supplementary Figures 
 
 
Figure S1. Wheel-running activity of ApoE+/+ mice in 12L:12D and constant 
darkness. Single-plotted actograms of wheel-running activity of individual female (a-e) 
and male (f-m) ApoE+/+ mice. Mice were housed in 12L:12D (LD, 0-12h is lights on and 
12-24h is lights off) for 7 days and then released into constant darkness (DD) for 7 days. 
x-axis: hours; y-axis: days. 
41 
 
 
Figure S2. Wheel-running activity of ApoE-/- mice in 12L:12D and constant 
darkness. Single-plotted actograms of wheel-running activity of individual female (a-g) 
and male (h-m) ApoE-/- mice. Mice were housed in 12L:12D (LD, 0-12h is lights on and 
12-24h is lights off) for 7 days and then released into constant darkness (DD) for 7 days. 
x-axis: hours; y-axis: days. 
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Figure S3. Daily activity levels and amplitudes of the locomotor activity rhythms in 
ApoE+/+ and ApoE-/- mice. Daily activity (wheel revolutions x 103) was averaged over 7 
days in 12L:12D (a, LD), constant darkness (b; DD) or constant light (LL). The 
amplitudes (Qp) of the wheel-running activity rhythms in DD were analyzed for days 1-7 
in DD (d). *p<0.05 
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Figure S4. Circadian behavior rhythms in constant light in ApoE-/- mice are 
indistinguishable from ApoE+/+ mice. Representative double-plotted actograms of 
wheel-running activity of ApoE+/+ (a) and ApoE-/- (b) mice housed in 12L:12D for 7 days 
(LD) and then released into constant light for 7 days (LL). Yellow shading shows lights 
on. The free-running periods (c) and amplitudes (d) were determined using 2 
periodograms for days 1-7 in constant light. There were no significant differences 
between ApoE+/+ and ApoE-/- mice. Data are mean ± SEM. 
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Figure S5. Wheel-running activity of ApoE+/+ and ApoE-/- mice in constant light. 
Double-plotted actograms of wheel-running activity of ApoE+/+ (a-e) and ApoE-/- (f-j) 
mice. Mice were housed in 12L:12D and then released into constant light for 21 days. 
Yellow shading shows lights on. x-axis: hours; y-axis: days. Females are shown in a, f, 
and g. Males are shown in b-e and h-j. 
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Figure S6. Phase responses to light pulses at CT 8-10 in ApoE+/+ and ApoE-/- mice. 
Single-plotted actograms of ApoE+/+ (a-d) and ApoE-/- (e-h) mice administered a single 
15-min light pulse (yellow bar) at circadian time (CT) 8-10 (subjective day) in constant 
darkness (x-axis: hours; y-axis: days). Males are shown in a, b and e-g. Females are 
shown in c, d, and h. 
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Figure S7. Phase responses to light pulses at CT 14-16 in ApoE+/+ and ApoE-/- mice. 
Single-plotted actograms of ApoE+/+ (a-f) and ApoE-/- (g-n) mice administered a single 
15-min light pulse (yellow bar) at circadian time (CT) 14-16 (early subjective night) in 
constant darkness (x-axis: hours; y-axis: days). Males are shown in a,b, and g-i. Females 
are shown in c-f and j-n. 
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Figure S8. Phase responses to light pulses at CT 21-23 in ApoE+/+ and ApoE-/- mice. 
Single-plotted actograms of ApoE+/+ (a-d) and ApoE-/- (e-l) mice administered a single 
15-min light pulse (yellow bar) at circadian time (CT) 21-23 (late subjective night) in 
constant darkness (x-axis: hours; y-axis: days). Males are shown in e and f. Females are 
shown in a-d and g-k. 
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Figure S9. PERIOD2::LUCIFERASE bioluminescence rhythms in ApoE+/+ and 
ApoE-/- tissues. Detrended bioluminescence recorded from tissue explants cultured from 
ApoE+/+ at 8 weeks old (gray traces), ApoE-/- mice at 8 weeks old (black traces), and 
ApoE-/- mice at 20 weeks old (blue traces) that were heterozygous PER2::LUC. The 
lighting condition on the day the tissues were cultured is indicated for the first day; open 
bars are light and black bars are dark. The tissues were cultured during the 2h before 
lights out. 
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Figure S10. Locomotor activity of female ApoE-/- mice in 12L:12D. Single-plotted 
actograms of locomotor activity of individual female ApoE-/- mice (a-r) housed in control 
12L:12D for 13 weeks (x-axis: hours; y-axis: days). 
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Figure S11. Locomotor activity of female ApoE-/- mice in constant light. Single-
plotted actograms of locomotor activity of individual female ApoE-/- mice (a-u; x-axis: 
hours; y-axis: days). The mice were housed in 12L:12D (0h is lights on and 12h is lights 
off) for 1 week and then released into constant light for 12 weeks. One actogram was 
excluded due to a faulty infrared sensor. 
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Figure S12. Locomotor activity of male ApoE-/- mice in 12L:12D. Single-plotted 
actograms of locomotor activity of individual male ApoE-/- mice (a-r) housed in control 
12L:12D (0h is lights on and 12h is lights off) for 13 weeks (x-axis: hours; y-axis: days). 
One actogram was excluded due to a faulty infrared sensor. 
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Figure S13. Locomotor activity of male ApoE-/- mice in constant light. Single-plotted 
actograms of locomotor activity of individual male ApoE-/- mice (a-p; x-axis: hours; y-
axis: days). The mice were housed in 12L:12D (0 h is lights on and 12h is lights off) for 1 
week and then released into constant light for 12 weeks. 
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Figure S14. Chronic constant light (LL) exposure disrupts general locomotor 
activity rhythms in ApoE-/- mice. ApoE-/- mice were housed in LL for 12 weeks. 2 
periodograms were used to determine whether general locomotor activity was rhythmic 
in the final 28 days in constant light. Activity was rhythmic if a dominant peak exceeded 
alpha set at p=0.001 (period range 20-36h). 
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Figure S15. Constant light exposure does not alter cholesterol concentration and 
lipoprotein distribution in female ApoE-/- mice. Total serum cholesterol concentrations 
(a) and distribution of cholesterol on lipoproteins (b, mean ± SEM; FPLC was performed 
on n=4-5/group) of female ApoE-/- mice housed in control 12L:12D or constant light for 
12 weeks. In a, data from individual mice are closed symbols and open symbols are mean 
± SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
 
 
Figure S16. Constant light exposure does not alter serum triglyceride concentrations 
in male and female ApoE-/- mice. Total serum triglyceride concentrations of male (a) 
and female (b) ApoE-/- mice housed in control 12L:12D or constant light for 12 weeks. 
Data from individual mice are closed symbols and open symbols are mean ± SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
CHAPTER 3. THE EFFECTS OF CHRONIC JET LAG ON ATHEROSCLEROSIS IN 
APOLIPOPROTEINE-DEFICIENT MICE 
3.1 Introduction 
The mammalian circadian system is an endogenous timekeeping mechanism that 
entrains rhythmic biological processes with environmental cycles, such as the light-dark 
cycle3. It is organized hierarchically. The central clock, the suprachiasmatic nucleus 
(SCN) in the hypothalamus, receives information about the environmental light-dark 
cycle from the retina and then coordinates the phases of peripheral clocks located in 
nearly every tissue in the body70,71. This finely tuned relationship is believed to 
coordinate internal biological processes with environmental cycles and thereby confer 
good health. However, work, school, and social obligations, which cause exposure to 
artifical light at night, disrupt meal timing, and alter sleep/wake patterns, disrupt this 
finely tuned system217,233,246,247. 
Approximately 21 million Americans are shift workers who work outside of the 
traditional daytime schedule201. Shift workers experience abnormal exposure to light and 
have disrupted eating and activity/sleeping patterns272,273. Epidemiological studies have 
demonstrated that exposure to light at night is associated with increases in obesity-related 
parameters and the development of cardiovascular disease (CVD)247,274. Shift work also 
increases the risk for gastrointestinal problems, dyslipidemia, disrupted glucose 
metabolism, obesity, and cancers, strongly suggesting that disruption of circadian 
rhythms is associated with negative health consequences275-281. It is possible that some of 
the mechanisms linking circadian disruption and poor health may be influenced by the 
disrupted dietary habits of shift workers273. 
Clinical studies designed to mimic shift work conditions have demonstrated a link 
between shift work and metabolic dysfunction and cardiovascular disease (CVD). Two 
studies simulated the disordered exposure to light and food, much like shift workers 
experience, by inverting the light-dark cycle or having seven recurring 28-hour days 
respectively, in young, healthy volunteers217,225. Simulated shift work caused acute 
hypertension, increased pro-inflammatory markers, and increased markers for metabolic 
disease217,225. Another study recruited healthy shift workers to undergo simulated 
nightshift or dayshift for three consecutive days. The nightshift group had increased  
blood pressure and levels of the inflammatory marker C-reactive protein282. These studies 
demonstrated that short-term circadian disruption causes metabolic dysfunction and CVD 
risk factors in humans. 
Preclinical studies have shown that circadian disruption causes CVD in mice. One 
way to induce circadian disruption in mice is to mutate the core circadian timekeeping 
genes. Studies involving mutations in Bmal1, Clock, or Rev-erbα showed marked 
increases in circulating lipids, higher concentrations of circulating atherogenic 
macrophages, and an overall increase in atherosclerosis218-221. However, these gene 
manipulation studies do not mimic the type of circadian disruption experienced by shift 
workers. Other studies have investigated the effects of light-induced circadian disprution 
that is more translatable to humans. One study found that atherosclerosis was increased in 
female hyperlipidemic mice exposed to weekly alternating light-dark cycles for 15 
weeks227. They concluded that the vessel walls in mice in the light disruption condition 
had higher macrophage content and increased inflammatory and oxidative stress 
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markers227. A recent study from our lab demonstrated that male ApoE-/- mice housed in 
constant light for 12 weeks had increased atherosclerosis and pro-atherogenic 
VLDL/LDL cholesterol compared to controls228. However, the mechanisms linking 
circadian disruption and CVD remain largely unknown.  
The goal of the current study was to utilize a light-induced model of circadian 
disruption, that better approximates the disruption experienced by shift workers, to 
elucidate the mechanisms linking circadian disruption and CVD.  
 
3.2 Materials and Methods 
Chronic jet lag experimental protocol 
Male and female C57BL/6J ApoE-/- mice were generated and raised as previously 
described228. For all experiments, mice were singly-housed in cages (33 cm x 17 cm x 14 
cm) with locked running wheels (diameter: 11 cm) and fed low-fat diet (Research Diets 
D12450K, 10% kcal fat) and water ad libitum. At 7 weeks old, male and female ApoE-/- 
mice (backcrossed to C57BL/6J mice from The Jackson Laboratory for 11-12 
generations) were singly-housed in light-tight boxes in 12L:12D. General locomotor 
activity was continuously recorded with passive infrared sensors as previously 
descrbed228. At 8 weeks old, mice were randomized to either control 12L:12D or chronic 
jet lag (CJL) for 12 weeks. In the control condition, mice were maintained in the 
12L:12D lighting condition in which they were raised. In CJL, the time of lights off was 
advanced by 6-hours each week. Body weights and food were measured weekly between 
ZT9-ZT12, where ZT0 is lights on and ZT12 is lights off. Beginning at 8 weeks old, 
blood was serially sampled from each mouse every 4 weeks at ZT6 using the submental 
blood collection method283. At 20 weeks old, mice were anesthetized with inhaled 
isoflurane. Blood was collected by cardiac puncture and aortas and hearts were collected 
as previously described228. Atherosclerotic lesion area was quantified in the en face aorta 
as previously described228. Mice with gross organ abnormalities were excluded from the 
study (one mouse from the female 12L:12D control group was excluded for an enlarged 
kidney). 
 
Analysis of eating behavior rhythms 
 Eating behavior was continuously monitored for 2 weeks. The mice were in 
control 12L:12D for 1 week and then in the CJL condition for 1 week. Eating behavior 
was video recorded using infrared cameras (HD 48LED 940nm CMOS 800TVL IR-CUT 
Dome camera waterproof IF CCTV) on a Lorex DVR system (MPX HD 1080p Security 
System DVR). Eating behavior data was analyzed as previouly described251. Briefly, 
eating behavior events were analyzed for each day in 1-minute bins. Twenty-four hours 
of data were then plotted in circular histograms using Oriana 4.0 software. Circular 
statistics were used to determine the vector of one day of eating behavior. The vector 
length and direction were defined as the amplitude and phase of the eating behavior 
rhythm, respectively. 
  
3.3 Results 
The experiments described herein are ongoing. Therefore, statistsical anlayses have 
not yet been performed. The data will be statistically analyzed when there are at least 20 
mice/group. Results for a subset of the en face data are pending analysis by a second 
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investigator who is blinded to the experimental conditions. Analyses of total cholesterol 
and total triglycerides have been performed in only a subset of the samples. 
 
Chronic jet lag and atherosclerosis in male and female ApoE-/- mice 
Male and female ApoE-/- mice were housed in control 12L:12D (Fig. 7a) or 
chronic jet lag (CJL) conditions (Fig. 7b) for 12 weeks. In the CJL condition, the light-
dark cycle was advanced by 6-hours every week. Female ApoE-/- mice in the CJL 
condition had a 70% increase in atherosclerosis in the en face aorta compared to those in 
control 12L:12D (Fig. 7c). Male ApoE-/- mice had a 36% increase in atherosclerosis in the 
en face aorta compared to those in control 12L:12D (Fig. 7d). 
 
Chronic jet lag and serum lipids in male and female ApoE-/- mice 
To better understand how CJL may contribute to atherosclerosis in ApoE-/- mice, 
we measured factors that have been previously shown to increase atherosclerosis in mice. 
CJL did not increase body weight in female (Fig. 8a) and male (Fig. 8b) ApoE-/- mice 
compared to their same-sex controls. Female ApoE-/- mice housed in CJL had a 23% 
increase total serum cholesterol (Fig. 9a) due to increased VLDL/LDL fractions (Fig. 9b) 
and a 27% increase in total serum triglycerides (Fig. 10a). Male ApoE-/- mice had a 0.6% 
decrease in total serum cholesterol (Fig. 9c) and a 15% increase in total serum 
triglycerides (Fig. 10b).   
 
Chronic jet lag disrupts eating behavior rhythms in ApoE-/- mice 
We next measured the effect of CJL on eating behavior rhythms because it has been 
shown that shift workers experience disrupted feeding/fasting rhythms, and disrupted 
meal timing can have negative cardiometabolic effects245,273. Female ApoE-/- mice housed 
in control 12L:12D exhibited robust daily rhythms of eating during ad libitum feeding 
(Fig. 11a). On the first day in the shifted light-dark cycle, (Fig. 11b), the amplitude of the 
eating behaivor rhythm was reduced by 17% in female ApoE-/- mice (Fig. 11c). 
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Figures 
 
Figure 7. Chronic jet lag and atherosclerosis in ApoE-/- mice. 
Representative actograms of general locomotor activity of female ApoE-/- mice housed in 
either control 12L:12D (a) or CJL conditions (b). Percent atherosclerotic lesion area 
measured from en face aortas of female (c) and male (d) ApoE-/- mice housed in control 
12L:12D (black) or CJL (red) for 12 weeks. Values from individual mice are filled circles 
and the means ± SEM are open circles (c,d). 
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Figure 8. The effects of chronic jet lag on body weight in ApoE-/- mice. 
Mean body weights (±SEM) of female (a) and male (b) ApoE-/- mice housed in control 
12L:12D (black) or CJL (red) for 12 weeks. 
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Figure 9. The effects of chronic jet lag on cholesterol in ApoE-/- mice. 
Total serum cholesterol concentrations in female (a) and male (c) and distribution of 
cholesterol in lipoproteins (n=3-4 mice/group) in female (b) ApoE-/- mice after 12 weeks 
in control 12L:12D (black) or CJL (red). Values from individual mice are filled circles 
and the means ± SEM are open circles (a,c). Distribution of cholesterol in lipoproteins 
has not been performed in males.  
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Figure 10. The effects of chronic jet lag on triglycerides in ApoE-/- mice.  
Total serum triglyceride concentrations in female (a) and male (b) ApoE-/- mice after 12 
weeks in control 12L:12D (black) or CJL (red). Values from individual mice are filled 
circles and the means± SEM are open circles (a,b). 
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Figure 11. Chronic jet lag alters eating behavior rhythms in female ApoE-/- mice.  
Eating behavior was continuously recorded by infrared video cameras in female ApoE-/- 
mice housed in control 12L:12D (a) or CJL (b) and the amplitude of the eating behavior 
rhythms (c) were analyzed. 
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CHAPTER 4. DISCUSSION 
Cardiovascular disease (CVD) is the leading cause of death in America and 
affects more than 121 million individuals112,284. There are several well-established risk 
factors for CVD including cigarette smoking, dyslipidemia, obesity, hypertension, and 
age.113,135-140. Evidence from epidemiological and clinical studies have also demonstrated 
that shift work is associated with CVD215,216,233,285. Shift workers experience chronic 
misalignment between internal circadian rhythms and external cycles (e.g., the 
environmental light-dark cycle)272,273. Together these findings suggest that circadian 
disruption increases the risk for developing CVD.  
In addition to the epidemiological studies of shift workers, there is growing 
evidence demonstrating a link between circadian disruption and CVD. In a clinical study, 
young, healthy adults exposed to short-term, light-induced circadian disruption developed 
CVD risk factors217,225,282,286. Additionally, disrupted timing of food intake (e.g., 
breakfast skipping and late-night eating) in humans is associated with CVD risk factors 
including obesity, impaired glucose metabolism, and elevated LDL cholesterol245,287,288. 
Studies in mice with circadian gene mutations have provided causal evidence that genetic 
disruption of the molecular circadian clock increases atherosclerosis218-221. Together, 
these studies strongly support a link between circadian disruption and the development of 
CVD. 
In our studies, we sought to investigate the role of light-induced circadian 
disruption on atherosclerosis in mice. While previous studies demonstrated that genetic 
disruption of circadian clocks caused atherosclerosis, our studies are novel in that they 
more closely resemble the type of environmental circadian disruption experienced by 
shift workers. To pursue these studies, we first needed an appropriate preclinical model. 
An ideal mouse model for our studies should meet two criteria. First, the mouse must 
develop atherosclerosis without requiring consumption of a diet high in fat. Consuming 
high-fat diet disrupts eating behavior rhythms, shifts the timing of the liver circadian 
clock, increases body weight, and promotes the development of markers of metabolic 
syndrome in mice and we sought to exclude these factors251,252. Second, the mouse model 
must have no inherent disruption of their circadian rhythms otherwise we would not be 
able to distinguish between the effects of light-induced disruption and inherent circadian 
disruption on atherogenic mechanisms. The low-density lipoprotein receptor deficient 
(Ldlr-/-) and the ApolipoproteinE-deficient (ApoE-/-) mice are the most commonly used 
mouse models of atherosclerosis198. Unlike Ldlr-/- mice, ApoE-/- mice spontaneously 
develop atherosclerosis at 12 weeks when fed low-fat diets197. A previous study 
suggested that ApoE-/- mice had altered entrainment to the light-dark cycle, had 
attenuated behavioral responses to light pulses, and altered phases of circadian gene 
expression in the SCN compared to wild-type mice253. However, this prior study had 
methodological and technical drawbacks. We characterized circadian rhythms in ApoE-/- 
mice and found they had locomotor activity rhythms, circadian responsiveness to light, 
and molecular timekeeping rhythms in tissues that were similar to wild-type (C57BL/6J) 
mice. Thus ApoE-/- mice met our 2 criteria and were an appropriate mouse model for our 
studies228.  
Only 2 previous studies have investigated the effects of light-induced circadian 
disruption on atherosclerosis226. One study concluded that 12-hour inversions of the light-
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dark cycle increased atherosclerosis in male ApoE-/- mice226. However, this study 
analyzed only male ApoE-/- mice, the study was not properly powered, and 
atherosclerosis was not quantified. Another study found that inverting the light-dark cycle 
weekly increased atherosclerosis and the increase was attributed to a higher concentration 
of macrophages in the lesions227. However, only female mice were studied and mice 
consumed a Western-type (high-fat and high cholesterol) diet227. Our studies accounted 
for several of the weaknesses from the previous studies. The previous studies investigated 
the effects of light-induced disruption in either males or females, but not both. Our study 
design is unique in that we measured atherosclerosis in both sexes. We also fed our mice 
low-fat diet for the entirety of the study to exclude the negative effects of a high-fat diet. 
We exposed our mice to 2 forms of light-induced circadian disruption, constant 
light and chronic jet lag (CJL) conditions. Constant light renders locomotor activity 
arrhythmic in nocturnal rodents62,67. This form of environmental disruption was used to 
determine if severe light-induced disruption affected atherosclerosis. Our results showed 
that after 12 weeks of constant light exposure, male, but not female, ApoE-/- mice had 
significantly increased atherosclerosis in en face aortas and aortic roots compared to 
12L:12D controls228. To determine the mechanisms by which constant light increased 
atherosclerosis in male ApoE-/- mice, we measured serum lipids. We found that males 
exposed to constant light had increased serum cholesterol due to increased atherogenic 
VLDL/LDL fractions. These data demonstrate that constant light-induced circadian 
disruption increased atherosclerosis in male ApoE-/- mice by increased atherogenic 
VLDL/LDL-cholesterol.  
 The suprachiasmatic nucleus (SCN) regulates locomotor activity and eating 
behavior rhythms, and coordinates the timing of peripheral clocks (e.g. the liver clock)289. 
Disruption by constant light exposure causes the SCN to become arrhythmic, which 
results in severely disrupted or arrhythmic locomotor activity and eating62,250,290. The 
liver is considered to be the major site of control of cholesterol homeostasis291. It 
facilitates the clearance of chylomicron and VLDL remnants, synthesizes cholesterol 
(HDL), and is involved in excretion and reabsorption of cholesterol292. Since the SCN 
coordinates the timing of peripheral clocks, such as the liver, the effects of constant light 
cause peripheral clocks to become disrupted. This could be a potential mechanism linking 
constant light exposure and the increase in VLDL/LDL. 
Although effective at disrupting circadian rhythms, constant light is not a good 
translational model of human shift work because most humans do not experience 
arrhythmicity. A light-induced disruption model with more translational relevance would 
better approximate the highly variable sleep/work schedules that are experienced by shift 
workers272,273. In the CJL condition, the time of lights off is advanced by 6-hours each 
week (the lights turn off 6-hours earlier) and locomotor activity rhythms gradually shift 
to the new light-dark cycle. This model is an established model of light-induced circadian 
disruption and allows for samples of blood and tissues to be taken relative to the light-
dark cycle for measuring rhythms, which is impossible in mice in constant light, because 
there are no behavioral (activity) or environmental (light-dark transitions) cycles to use a 
reference point293. 
We found that CJL increased atherosclerosis in en face aortas in females by 70% 
and in males by 36% when compared to their respective 12L:12D controls. CJL increased 
serum cholesterol by 23% in females due to increased VLDL/LDL fractions. CJL also 
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increased triglycerides by 27% in females. In contrast, total cholesterol levels were 
equivalent in males in CJL and control 12L:12D and they had a 15% increase in 
triglycerides. Together, these data suggest that light-induced disruption via CJL may 
exacerbate atherosclerosis in ApoE-/- mice, possibly via altering atherogenic lipids in 
females. 
Although the light-dark cycle is the most salient entraining cue to the SCN, meal 
timing entrains the liver circadian clock independent of the SCN and can therefore cause 
internal desynchrony between the SCN and liver clocks. Feeding mice only during the 
daytime (in nocturnal rodents that typically eat at night), causes the circadian rhythm of 
the liver to synchronize with the time of food availability294,295. This disrupted feeding 
also has metabolic consequences. Mice fed high-fat diet during the daytime gained more 
weight than mice fed high-fat diet during the nighttime296. In contrast, mice fed high-fat 
diet only during the nighttime did not develop diet-induced obesity297. Additionally, meal 
timing in human shift workers is disrupted273. Compared to dayshift workers, night shift 
workers had a greater number of eating events and consumed a greater amount of fats. 
These aberrant eating patterns in shift workers have also been linked to higher rates of 
CVD risk factors. Breakfast skipping and late-night eating are associated with 
dyslipidemia, obesity, type 2 diabetes, disrupted glucose and insulin responses, 
hypertension, and increased risk of developing coronary heart disease256-261,298-300. Our 
preliminary data show that ApoE-/- mice housed in control 12L:12D and fed ad libitum 
had robust daily rhythms of eating behavior. However, when exposed to CJL, the 
rhythms of eating became disrupted. Considering the liver can be synchronized to the 
timing of food intake, independent of the SCN, the disruption in eating behavior in CJL 
could disrupt cholesterol homeostasis, thus causing the observed increase in VLDL/LDL. 
One study demonstrated that ApoE-/- mice lacking functional Bmal1 in liver hepatocytes 
had increased atherosclerosis, suggesting that the liver clock is important for cholesterol 
homeostais221. Since chronic elevated cholesterol is a risk factor for atherosclerosis, this 
could be a potential mechanism linking light-induced disruption and atherosclerosis.  
In future experiments, we can test whether CJL disruption of eating rhythms is a 
mechanism that increases atherosclerosis in ApoE-/- mice. Future studies could correct the 
CJL-induced disruption of eating behavior by restricting food only to the 12-hours of 
dark (i.e. the time when food is available will be at the new shifted time of darkness) and 
compare the results to ad libitum controls. If VLDL/LDL cholesterol and atherosclerosis 
are reduced in the time-restricted feeding group, then disruption of the eating rhythm 
contributes to dyslipidemia and atherosclerosis in CJL conditions.  
In summary, we have demonstrated that light-induced circadian disruption 
increases atherosclerosis in ApoE-/- males in constant light and females in CJL via 
increased VLDL/LDL cholesterol. Our preliminary results show that CJL disrupts the 
daily rhythm of eating behavior in female ApoE-/- mice. Together, these data suggest that 
light-induced disruption of meal timing could be a possible mechanism involved in the 
development of atherosclerosis. 
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